Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Lung Cancer,2012,NCI,5R01CA120247-07,,Mutant EGF Receptor-Dependent Lung Cancer in Human Cell Lines and Transgenic Mice,"POLITI, KATERINA",YALE UNIVERSITY,CT,"$293,295"
Lung Cancer,2012,NCI,4R01CA139612-03,,Role of Id1 in NSCLC Progression and Metastasis,"CHELLAPPAN, SRIKUMAR",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$344,596"
Lung Cancer,2012,NCI,5R01CA140409-03,,Development of Small Molecule Radiation Sensitizers,"FREEMAN, MICHAEL",VANDERBILT UNIVERSITY MED CTR,TN,"$360,940"
Lung Cancer,2012,NCI,5R01CA077429-13,,Basis for Lymphomagenesis in Akt2 Transgenic Mice,"TESTA, JOSEPH",FOX CHASE CANCER CENTER,PA,"$410,451"
Lung Cancer,2012,NCI,5R01CA127580-05,,Molecular Mechanisms of EGF Signaling & Iressa/Tarceva Inhibition in NSCLC,"ANDERSON, KAREN",YALE UNIVERSITY,CT,"$314,248"
Lung Cancer,2012,NCI,5R01CA127105-05,,FGF-2 Autocrine Signaling in Lung Cancer,"HEASLEY, LYNN",UNIVERSITY OF COLORADO DENVER,CO,"$303,684"
Lung Cancer,2012,NIAID,5R01AI073919-06,,Helicase Regulation of dsRNA Signaling and Innate Antiviral Immune Responses,"HORVATH, CURT",NORTHWESTERN UNIVERSITY,IL,"$377,571"
Lung Cancer,2012,NCI,5R01CA078814-14,,New Triterpenoids for Chemoprevention and Therapy of Cancer,"SPORN, MICHAEL",DARTMOUTH COLLEGE,NH,"$340,825"
Lung Cancer,2012,NCI,5R01CA077262-15,,Nucleoporins in Chromosomal Instability and Cancer,"VAN DEURSEN, JAN",MAYO CLINIC,MN,"$302,744"
Lung Cancer,2012,NCI,5R01CA109038-07,,"NKX2-1, A Candidate Lineage Survival Oncogene in Lung Adenocarcinoma","MEYERSON, MATTHEW",DANA-FARBER CANCER INSTITUTE,MA,"$424,375"
Lung Cancer,2012,NCI,5R01CA124951-03,,Novel CTD inhibitors with synthetic lethality to oncogenic Ras for cancer therapy,"FANG, BINGLIANG",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$309,964"
Lung Cancer,2012,NCI,5R01CA127532-05,,Molecular Epidemiology and Lung Cancer: A Nested Case-Control Study,"PERERA, FREDERICA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$380,657"
Lung Cancer,2012,NCI,5R01CA128801-04,,Lung carcinogenesis: Chemoprevention by Indole-3-carbinol,"KASSIE, FEKADU",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$243,140"
Lung Cancer,2012,NCI,5R01CA098018-10,,Kinetic analysis of Myc-induced carcinogenesis in vivo,"EVAN, GERARD",UNIV OF CALIFORNIA AT SAN FRANCISCO,CA,"$327,831"
Lung Cancer,2012,NCI,5R01CA124495-04,,The Role of RAC1 in Cancer,"KISSIL, JOSEPH",WISTAR INSTITUTE,PA,"$211,258"
Lung Cancer,2012,NCI,5R01CA134796-04,,Investigating the role of p73 and its isoforms in tumorigenesis and metastasis,"FLORES, ELSA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$309,964"
Lung Cancer,2012,NCI,5R01CA039504-26,,Aldo-Keto Reductases and PAH Metabolism/Activation,"PENNING, TREVOR",UNIVERSITY OF PENNSYLVANIA,PA,"$280,504"
Lung Cancer,2012,NCI,5R01CA093626-09,,4D IMRT: Stereotactic body radiotherapy for lung cancer,"KEALL, PAUL",UNIVERSITY OF SYDNEY,AUSTRA,"$259,967"
Lung Cancer,2012,NCI,5R01CA154699-02,,Mechanistic Elaboration of Fragility in the Cancer Cell Mitotic Spindle,"WHITEHURST, ANGELIQUE",UNIVERSITY OF N CAROLINA AT CHAPEL HILL,NC,"$302,525"
Lung Cancer,2012,NCI,5R01CA108610-07,,Peroxisome Proliferator-Activated Receptor (gamma) in Lung Cancer,"NEMENOFF, RAPHAEL",UNIVERSITY OF COLORADO DENVER,CO,"$297,398"
Lung Cancer,2012,NCI,5R01CA151433-03,,Multimodal Image-Guided Intervention System for Lung-Cancer Diagnosis and Staging,"HIGGINS, WILLIAM",PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,PA,"$379,661"
Lung Cancer,2012,NCI,5R01CA073756-13,,Ras-Induced Lung Cancer: Key Roles for IKK and NF-kappaB,"BALDWIN, ALBERT",UNIVERSITY OF N CAROLINA AT CHAPEL HILL,NC,"$252,369"
Lung Cancer,2012,NCI,5R01CA136799-03,,Regulation of Ras and Rho Family GTPases in Lung Cancer,"WILLIAMS, CAROL",MEDICAL COLLEGE OF WISCONSIN,WI,"$305,938"
Lung Cancer,2012,NCI,5R01CA138759-03,,Stat3 Downstream Genes as Lung Adenocarcinoma Biomarkers,"YAN, CONG",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$343,545"
Lung Cancer,2012,NCI,7R01CA144034-03,,Prospective studies of cancer etiology and prevention in Shanghai and Singapore,"YUAN, JIAN-MIN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$1,506,354"
Lung Cancer,2012,NCI,5R01CA140416-03,,Antifolate activators of AMP-dependent protein kinase,"MORAN, RICHARD",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$290,459"
Lung Cancer,2012,NCI,5R01CA127725-05,,Role of Beta-arrestin-1 and Src in nAChR Signaling and Lung Caancer,"CHELLAPPAN, SRIKUMAR",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$336,129"
Lung Cancer,2012,NCI,5R01CA129491-03,,Identifying antigens bound by novel scFvs targeting all subtypes of mesothelioma,"LIU, BIN",UNIV OF CALIFORNIA AT SAN FRANCISCO,CA,"$310,970"
Lung Cancer,2012,NCI,5R01CA155061-02,,Multifunctional PEG Hydrogel Nano/Microparticles for Targeted Treatment of NSCLC,"SINKO, PATRICK",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$369,141"
Lung Cancer,2012,NIEHS,5K08ES019615-02,,Biomarkers of exposure and response to environmental tobacco smoke in the pancrea,"YU, KENNETH",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$180,684"
Lung Cancer,2012,NIEHS,5R01ES010807-12,,Molecular Mechanisms of Complex Mixture Toxicity,"PUGA, ALVARO",UNIVERSITY OF CINCINNATI,OH,"$452,014"
Lung Cancer,2012,NCI,5R01CA112557-07,,Molecular Mechanisms of Nickel-induced Tumorigenicity.,"HUANG, CHUANSHU",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$25,001"
Lung Cancer,2012,NCI,5R01CA131301-04,,Let-7 microRNAs in Lung Cancer: Altering Growth and Radioresistance,"WEIDHAAS, JOANNE",YALE UNIVERSITY,CT,"$332,762"
Lung Cancer,2012,NCI,5R01CA100193-10,,Analysis of the p53  in vivo using a unique mouse model,"EVAN, GERARD",UNIV OF CALIFORNIA AT SAN FRANCISCO,CA,"$330,583"
Lung Cancer,2012,NIEHS,5R21ES018998-03,,Targeting Fra-1 in Toxicant-Induced Lung Tumor Initiation & Development,"POTHIREDDY, SEKHAR",UNIVERSITY OF ILLINOIS,IL,"$196,250"
Lung Cancer,2012,NCI,5R01CA148722-03,,Imaging Cellular Stress and Treatment Response Using Positron Emission Tomography,"SHIELDS, ANTHONY",WAYNE STATE UNIVERSITY,MI,"$305,470"
Lung Cancer,2012,NCI,5R01CA131199-05,,Small Animal Image-Guided Radiotherapy,"GRAVES, EDWARD",STANFORD UNIVERSITY,CA,"$318,170"
Lung Cancer,2012,NCI,5R01CA079882-13,,Targeting the HGF/c-Met Pathway in Lung Cancer,"SIEGFRIED, JILL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$290,629"
Lung Cancer,2012,NCI,5R01CA140492-03,,Regulation of Tumorigenesis and therapeutic resistance by Nrf2 in lung cancer,"BISWAL, SHYAM",JOHNS HOPKINS UNIVERSITY,MD,"$319,010"
Lung Cancer,2012,NCI,5R01CA129835-05,,LPD Nanoparticles in Anti-Cancer Therapy,"HUANG, LEAF",UNIVERSITY OF N CAROLINA AT CHAPEL HILL,NC,"$292,520"
Lung Cancer,2012,NCI,5R01CA095568-10,,Biomarkers to Assess Selenium Chemoprevention for NSCLC,"BELINSKY, STEVEN",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$587,466"
Lung Cancer,2012,NCI,5R01CA149668-03,,Targeting apoptosis via chemical design of Bcl-2 antagonists,"PELLECCHIA, MAURIZIO",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$384,435"
Lung Cancer,2012,NCI,5R01CA122474-05,,Mechanistic Studies on Lung Cancer Prevention by Tea Polyphenols,"YANG, CHUNG",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$310,312"
Lung Cancer,2012,NCI,5R01CA126944-05,,Novel Immune Pathways for Lung Cancer Therapy,"SHARMA, SHERVEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$278,968"
Lung Cancer,2012,NCI,5R01CA133021-05,,Inhibition of Lung Carcinogenesis by Tea Polyphenols and Atorvastatin,"YANG, CHUNG",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$309,873"
Lung Cancer,2012,NCI,5R21CA155164-02,,Development of a Genome-wide Unbiased Screen for Identifying miRNA Target Genes,"WELLS, JULIE",JACKSON LABORATORY,ME,"$195,424"
Lung Cancer,2012,NCI,5R01CA141144-03,,Fibroblast Activation Protein in the Tumor Microenvironment in Lung Cancer,"PURE', ELLEN",WISTAR INSTITUTE,PA,"$300,300"
Lung Cancer,2012,NCI,5R01CA129933-05,,Circumventing Acquired Resistance to Growth Factor Receptor Kinase Inhibitors,"HABER, DANIEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$356,257"
Lung Cancer,2012,NCI,5R01CA129343-05,,RRM1 in the Management of Lung Cancer,"BEPLER, GEROLD",WAYNE STATE UNIVERSITY,MI,$1
Lung Cancer,2012,NCI,1R01CA163293-01,,Pulmonary Rehabiltation before Lung Cancer Resection,"BENZO, ROBERTO",MAYO CLINIC,MN,"$351,511"
Lung Cancer,2012,NIEHS,1R01ES021110-01,,Inflammasomes in pathogenesis of mesothelioma,"SHUKLA, ARTI",UNIVERSITY OF VERMONT & ST AGRIC COLLEGE,VT,"$343,125"
Lung Cancer,2012,NIEHS,1R01ES020870-01,,Cell survival and arsenic carcinogenesis,"SHI, XIANGLIN",UNIVERSITY OF KENTUCKY,KY,"$334,125"
Lung Cancer,2012,NCI,1R01CA164273-01,,Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors,"SHAW, ALICE",MASSACHUSETTS GENERAL HOSPITAL,MA,"$353,463"
Lung Cancer,2012,NCI,1R01CA163896-01,,In vivo murine models of metastasis for therapeutic testing,"SHARPLESS, NORMAN",UNIVERSITY OF N CAROLINA AT CHAPEL HILL,NC,"$412,209"
Lung Cancer,2012,NCI,1R01CA164147-01,,Role of HDAC6 in platinum resistance of non-small cell lung cancer,"ZHANG, XIAOHONG",UNIVERSITY OF SOUTH FLORIDA,FL,"$339,386"
Lung Cancer,2012,NCI,5R03CA156301-02,,An NF-kB inhibitor as a post-carcinogen lung cancer chemopreventive agent,"XING, CHENGGUO",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$71,689"
Lung Cancer,2012,NCI,5R01CA142842-03,,Sensitive and Specific Molecular Imaging of Pulmonary Nodules,"DRIEHUYS, BASTIAAN",DUKE UNIVERSITY,NC,"$304,538"
Lung Cancer,2012,NCI,1R15CA158677-01A1,,"A Role of Bit1 in the Apoptosis Resistance, Anoikis Insensitvity, and Chemoresist","BILIRAN, HECTOR",XAVIER UNIVERSITY OF LOUISIANA,LA,"$362,890"
Lung Cancer,2012,NIGMS,5R01GM072611-07,,Statistical Methods for Ultrahigh-dimensional Biomedical Data,"FAN, JIANQING",PRINCETON UNIVERSITY,NJ,"$266,915"
Lung Cancer,2012,NIGMS,5R01GM076343-07,,Structural Basis of Cytochrome P450 Activity,"SCOTT, EMILY",UNIVERSITY OF KANSAS LAWRENCE,KS,"$315,393"
Lung Cancer,2012,NCI,5R01CA100750-09,,Role of c-Met in SCLC and Potential for Novel Therapy,"SALGIA, RAVI",UNIVERSITY OF CHICAGO,IL,"$241,067"
Lung Cancer,2012,NCI,5R37CA081301-14,,Metabolism of Carcinogenic Tobacco-Specific Nitrosamines,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$500,375"
Lung Cancer,2012,NCI,5R01CA090687-11,,Cyclin-Dependent Kinase Inhibition During S Phase,"SHAPIRO, GEOFFREY",DANA-FARBER CANCER INSTITUTE,MA,"$306,173"
Lung Cancer,2012,NCI,5R01CA152301-03,,Predicting Adjuvant Chemotherapy Response in Lung Cancer,"XIE, YANG",UNIV OF TX SW MED CTR-DALLAS,TX,"$334,336"
Lung Cancer,2012,NCI,5R01CA142794-03,,Characterization and therapeutic targeting of HIF in LKB1 - deficient lung cancer,"KIM, WILLIAM",UNIVERSITY OF N CAROLINA AT CHAPEL HILL,NC,"$296,590"
Lung Cancer,2012,NCI,5R01CA131261-04,,"Studying the initiation, progression and therapy of lung cancer in mouse models","MCMAHON, MARTIN",UNIV OF CALIFORNIA AT SAN FRANCISCO,CA,"$338,369"
Lung Cancer,2012,NCI,1K08CA163941-01,,Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer,"MOON, EDMUND",UNIVERSITY OF PENNSYLVANIA,PA,"$173,772"
Lung Cancer,2012,NCI,1R21CA164740-01,,Analysis of lung cancer stem cell radioresistance,"LEVINA, VERA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$164,756"
Lung Cancer,2012,NCI,2P30CA006516-47,6055,Lung Cancer,"CHRISTIANI, DAVID",HARVARD UNIVERSITY (SCH OF PUBLIC HLTH),MA,"$92,581"
Lung Cancer,2012,NIEHS,5R01ES017009-03,,Nicotinic Receptor Ligands and Tobacco-induced Lung Cancer,"GRANDO, SERGEI",UNIVERSITY OF CALIFORNIA IRVINE,CA,"$340,808"
Lung Cancer,2012,NCI,5R01CA149462-03,,A genomewide study of lung cancer in never smokers,"GORLOVA, OLGA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$1,025,637"
Lung Cancer,2012,NCI,5R01CA154755-02,,Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy,"PEREZ-SOLER, ROMAN",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$402,645"
Lung Cancer,2012,NCI,5R03CA153961-02,,Inhibition in the progression of preinvasive lung cancer by pomegranate.,"KHAN, NAGHMA",UNIVERSITY OF WISCONSIN MADISON,WI,"$74,250"
Lung Cancer,2012,NCI,5R21CA152505-02,,Modulation of miR-31 by dietary zinc deficiency in rat esophageal carcinogenesis,"FONG, LOUISE",THOMAS JEFFERSON UNIVERSITY,PA,"$168,563"
Lung Cancer,2012,NCI,5R01CA127477-04,,Lung radioprotection by inhibition of TNF-alpha and TGF-beta1,"ZHANG, MING",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$309,719"
Lung Cancer,2012,NCI,5R01CA115707-07,,Targeting Notch3 in Lung Cancer,"DANG, THAO",UNIVERSITY OF VIRGINIA,VA,"$214,270"
Lung Cancer,2012,NCI,1U01CA157442-01A1,,"Prognostic value of tumor hypoxia, as measured by 18F-FMISO Breath Hold PET/CT","NEHMEH, SADEK",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$630,024"
Lung Cancer,2012,NCI,5R01CA102353-07,,Molecular Approaches to Early Detection of Lung Cancer,"MASSION, PIERRE",VANDERBILT UNIVERSITY MED CTR,TN,"$262,459"
Lung Cancer,2012,NCI,1R15CA165202-01,,Rho GTPases and Neuroprotection Model in Cancer Therapy,"LU, QUN",EAST CAROLINA UNIVERSITY,NC,"$421,566"
Lung Cancer,2012,NCI,5R01CA142858-02,,Control of lung cancer invasion and metastasis by vimentin,"MARCUS, ADAM",EMORY UNIVERSITY,GA,"$321,625"
Lung Cancer,2012,NIDCR,5R01DE014173-11,,EPITHELIAL ACETYLCHOLINE IN ORAL BIOLOGY AND PATHOLOGY,"GRANDO, SERGEI",UNIVERSITY OF CALIFORNIA IRVINE,CA,"$363,641"
Lung Cancer,2012,NCI,5R01CA135380-04,,Small-molecule Inhibition of the Interactions of the Urokinase Receptor:  A Targe,"MEROUEH, SAMY",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$247,971"
Lung Cancer,2012,NCI,5U01CA143062-03,,Radiomics of NSCLC,"GILLIES, ROBERT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$710,166"
Lung Cancer,2012,NCI,5R21CA153017-02,,Notch and stem cells in lung cancer treated with erlotinib plus notch inhibitor.,"GIBBONS, DON",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$253,472"
Lung Cancer,2012,NIEHS,5R01ES015662-05,,Mutagenesis of p53 by reactive PAH and ROS,"FIELD, JEFFREY",UNIVERSITY OF PENNSYLVANIA,PA,"$307,277"
Lung Cancer,2012,NCI,1P01CA154291-01A1,6711,Targeted Radiotherapy of Neoplastic Meningitis using Monoclonal Antibodies Label,"ZALUTSKY, MICHAEL",DUKE UNIVERSITY,NC,"$344,787"
Lung Cancer,2012,NCI,1R01CA158540-01A1,,Functional characterization of the long non-coding RNA Scirocco in development an,"SAUER, FRANK",UNIVERSITY OF CALIFORNIA RIVERSIDE,CA,"$309,577"
Lung Cancer,2012,NCI,5R01CA151601-02,,"Nicotine, nicotinic receptors and lung cancer","SPINDEL, ELIOT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$515,954"
Lung Cancer,2012,NCI,1P01CA154303-01A1,6769,Identification and Study of Novel EGFR Kinase Inhibtors,"JANNE, PASI",DANA-FARBER CANCER INSTITUTE,MA,"$429,576"
Lung Cancer,2012,NCI,1P01CA154303-01A1,6770,Identification of TBK1 inhibitors in KRAS-dependent lung cancer,"HAHN, WILLIAM",DANA-FARBER CANCER INSTITUTE,MA,"$429,576"
Lung Cancer,2012,NCI,1P01CA154303-01A1,6771,DDR2 kinase inhibition in squamous cell lung carcinomas,"MEYERSON, MATTHEW",DANA-FARBER CANCER INSTITUTE,MA,"$426,614"
Lung Cancer,2012,NCI,1P01CA154303-01A1,6772,Chemistry,"GRAY, NATHANAEL",DANA-FARBER CANCER INSTITUTE,MA,"$42,819"
Lung Cancer,2012,NCI,1P01CA154303-01A1,6773,Structure,"ECK, MICHAEL",DANA-FARBER CANCER INSTITUTE,MA,"$298,924"
Lung Cancer,2012,NCI,1P01CA154303-01A1,6774,Animal Models/Experimental Therapeutics Core,"WONG, KWOK KIN",DANA-FARBER CANCER INSTITUTE,MA,"$87,099"
Lung Cancer,2012,NCI,1P01CA154303-01A1,6775,Administration,"MEYERSON, MATTHEW",DANA-FARBER CANCER INSTITUTE,MA,"$169,754"
Lung Cancer,2012,NCI,2R01CA121210-06,,Overcoming acquired resistance to EGFR inhibitors in lung cancer,"PAO, WILLIAM",VANDERBILT UNIVERSITY MED CTR,TN,"$302,574"
Lung Cancer,2012,NHLBI,1R01HL107404-01A1,,Motivational Incentives to Reduce Secondhand Smoke in NICU Infants' Homes,"STOTTS, ANGELA",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$650,654"
Lung Cancer,2012,NCI,1R01CA157409-01A1,,A Decision Aid with HRQL Assessment to Reduce Costs in the Treatment of NSCLC,"HOLLEN, PATRICIA",UNIVERSITY OF VIRGINIA,VA,"$660,655"
Lung Cancer,2012,NCI,5R01CA136596-04,,"The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis","CONNOLLY, DENISE",FOX CHASE CANCER CENTER,PA,"$323,047"
Lung Cancer,2012,NCI,5R01CA087546-12,,Lung Cancer Prevention Mechanisms,"DMITROVSKY, ETHAN",DARTMOUTH COLLEGE,NH,"$270,629"
Lung Cancer,2012,NIEHS,5R01ES018883-03,,HIF-alphia in Cr(VI) carcinogenesis,"ZHANG, ZHUO",UNIVERSITY OF KENTUCKY,KY,"$330,784"
Lung Cancer,2012,NIEHS,5R03ES019929-02,,Plk3 in lung cancer,"XU, DAZHONG",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$80,000"
Lung Cancer,2012,NCI,1K23CA159391-01A1,,Anti-Tumor Immunity in Response to a Modified Vaccine Strain Measles Virus,"PEIKERT, TOBIAS",MAYO CLINIC,MN,"$164,160"
Lung Cancer,2012,NIEHS,5R01ES016893-04,,Particulate Cr(VI) Toxicology in Human Lung Epithelial Cells and Fibroblasts,"WISE, JOHN",UNIVERSITY OF SOUTHERN MAINE,ME,"$329,682"
Lung Cancer,2012,NCI,5R01CA143111-03,,Screening Lung Cancer by Ultra Low-Dose Computed Tomography,"LIANG, JEROME",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$314,080"
Lung Cancer,2012,NIEHS,5R01ES017328-03,,Bridging Inflammation and Cigarette Smoke-associated Lung Carcinogenesis by MUC1,"LIN, YONG",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$427,112"
Lung Cancer,2012,NCI,5R01CA157450-02,,Regulation of Lung Cancer Metastasis by miR-200,"KURIE, JONATHAN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$324,729"
Lung Cancer,2012,NCI,5U01CA069856-18,,Early Clinical Trials of New Anti-Cancer Agents with Phase 1 Emphasis,"SPRIGGS, DAVID",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$245,639"
Lung Cancer,2012,NCI,5R01CA140571-02,,Pro-Oncogenic Role of LKB1 in NSCLC,"ZHOU, WEI",EMORY UNIVERSITY,GA,"$321,625"
Lung Cancer,2012,NCI,5R01CA142787-03,,Role of DOK family proteins in lung tumor suppression,"PANDOLFI, PIER PAOLO",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$350,219"
Lung Cancer,2012,NCI,5R01CA118130-05,,PET Proliferation Tracers,"SCHWARTZ, JEFFREY",UNIVERSITY OF WASHINGTON,WA,"$304,178"
Lung Cancer,2012,NCI,5R01CA126801-04,,Role of CREB in Lung Cancer Development,"KOO, JA SEOK",YALE UNIVERSITY,CT,"$338,783"
Lung Cancer,2012,NCI,1R21CA158965-01A1,,Synergism of c-Met and EGFR pathways: their therapeutic role in lung cancer,"PURI, NEELU",UNIVERSITY OF ILLINOIS,IL,"$175,000"
Lung Cancer,2012,NCI,1R03CA159369-01A1,,Mechanism of chemopreventive synergism from the combination of EGCG and Erlotinib,"AMIN, A.R.M.",EMORY UNIVERSITY,GA,"$77,500"
Lung Cancer,2012,NCI,5R01CA144053-03,,Chemopreventive effect of fish oil derived EPA in lung cancer,"YANG, PEIYING",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$318,015"
Lung Cancer,2012,NCI,5U01CA084306-14,,Integrative genomic characterization of lung cancer metastasis in mouse and human,"JACKS, TYLER",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$741,628"
Lung Cancer,2012,NCI,5R01CA132566-05,,Inflammation and Lung Carcinogenesis,"JABLONS, DAVID",UNIV OF CALIFORNIA AT SAN FRANCISCO,CA,"$284,744"
Lung Cancer,2012,NCI,5U10CA021661-36,,Radiation Therapy Oncology Group,"CURRAN, WALTER",AMERICAN COLLEGE OF RADIOLOGY,VA,"$12,915,055"
Lung Cancer,2012,NCI,5R01CA132571-05,,Regulation of Tumor Associated Macrophages by TGF-beta,"KESHAMOUNI, VENKATESHWAR",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$278,574"
Lung Cancer,2012,NCI,5R01CA132586-05,,Pulmonary inflammation and lung cancer development and progression,"KARIN, MICHAEL",UNIVERSITY OF CALIFORNIA AT SAN DIEGO,CA,"$327,195"
Lung Cancer,2012,NCI,5R01CA149490-02,,Studying measurement variability in tumor volume and volume change on MDCT,"ZHAO, BINSHENG",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$341,345"
Lung Cancer,2012,NCI,5R01CA154365-02,,Identification and Characterization of Gene Fusions in Lung Adenocarcinoma,"BEER, DAVID",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$286,245"
Lung Cancer,2012,NIEHS,5R01ES017777-03,,The Epigenetic Mechanism of Arsenic Lung Carcinogenesis - Role of MicroRNAs,"YANG, CHENGFENG",MICHIGAN STATE UNIVERSITY,MI,"$339,026"
Lung Cancer,2012,NIEHS,1R01ES020591-01A1,,Mechanisms of arsenic-induced chromosomal instability and carcinogenesis,"DAI, WEI",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$400,910"
Lung Cancer,2012,NCI,5K22CA140719-02,,Asymmetric Cell Division and Notch Signaling in Lung Cancer Stem Cells,"PINE, SHARON",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$179,582"
Lung Cancer,2012,NIEHS,5R01ES017217-05,,Mdig gene and histone demethylation in lung cancer,"CHEN, FEI",WAYNE STATE UNIVERSITY,MI,"$301,674"
Lung Cancer,2012,NCI,5R01CA126818-05,,HDGF: a novel biomarker and therapetic target of lung cancer,"MAO, LI",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$390,636"
Lung Cancer,2012,NCI,5R01CA152005-03,,An Integrated Nano-Cell Delivery Platform of Theranostics for Lung Cancers,"MOHAPATRA, SHYAM",UNIVERSITY OF SOUTH FLORIDA,FL,"$295,874"
Lung Cancer,2012,NCI,1R43CA165448-01,,An agent for the treatment of lung cancer,"KOMNINOU, DESPINA","MEDICON, INC.",NY,"$299,999"
Lung Cancer,2012,NCI,5R01CA132603-05,,Mechansims of Lung Carcinogenesis Induced by Asbestos and Cigarette Smoke,"SULLIVAN, DEBORAH",TULANE UNIVERSITY OF LOUISIANA,LA,"$274,285"
Lung Cancer,2012,NCI,5R01CA134433-05,,MOLECULAR GENETICS OF LUNG TUMOR PROMOTION IN MICE,"YOU, MING",MEDICAL COLLEGE OF WISCONSIN,WI,"$307,951"
Lung Cancer,2012,NCI,1R43CA165542-01,,Discovering Microenvironments Promoting Pathological EMT using Array Technology,"SEROBYAN, NAIRA","MICROSTEM, INC.",CA,"$155,532"
Lung Cancer,2012,NCI,5R01CA102792-10,,Use of Beta-lapachone for Lung Cancer Chemotherapy,"BOOTHMAN, DAVID",UNIV OF TX SW MED CTR-DALLAS,TX,"$330,925"
Lung Cancer,2012,NCI,5R01CA101880-08,,Novel DNA-metalating Hybrid Anticancer Agents,"BIERBACH, ULRICH",WAKE FOREST UNIVERSITY,NC,"$220,019"
Lung Cancer,2012,NCI,5R01CA132624-05,,Macrophages and Inflammatory Mediators in Silica-Induced Carcinogenesis,"LASKIN, DEBRA",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$284,933"
Lung Cancer,2012,NIDCR,2R01DE013173-10A1,,Tumor Suppressor Qualities and Mechanisms of LZAP Activity,"YARBROUGH, WENDELL",VANDERBILT UNIVERSITY MED CTR,TN,"$390,000"
Lung Cancer,2012,NCI,5R01CA105155-09,,Kinase Signaling in Lung Tumorigenesis,"KURIE, JONATHAN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$243,904"
Lung Cancer,2012,NCI,5R01CA126993-05,,Respiratory Motion-Reduced Cone-Beam CT Guidance of Radiotherapy in Lung & Liver,"MAGERAS, GIKAS",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$502,844"
Lung Cancer,2012,NCI,5R01CA129501-05,,Role of Paxillin in Lung Cancer,"SALGIA, RAVI",UNIVERSITY OF CHICAGO,IL,"$318,450"
Lung Cancer,2012,NCI,5R01CA132608-05,,Inflammation in Oncogenic K-ras-induced Lung Tumorigenesis,"KURIE, JONATHAN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$189,462"
Lung Cancer,2012,NCI,5R01CA132591-05,,Role of DOK Proteins in Lung Cancer,"NIKI, MASARU",UNIVERSITY OF IOWA,IA,"$276,450"
Lung Cancer,2012,NCI,5R01CA106314-09,,Dmp1-p53/YY1 interplays and their roles in lung cancer development,"SUI, GUANGCHAO",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$258,676"
Lung Cancer,2012,NCI,5R01CA134503-04,,Notch-1 and IGF-1 crosstalk: new therapeutic strategies for NSCLC,"BOCCHETTA, MAURIZIO",LOYOLA UNIVERSITY CHICAGO,IL,"$300,906"
Lung Cancer,2012,NCI,5R01CA140991-04,,Targeting Glucose Metabolism in Cancer,"TELANG, SUCHETA",UNIVERSITY OF LOUISVILLE,KY,"$227,884"
Lung Cancer,2012,NCI,5R01CA149045-03,,Use and Outcomes of Radiation Therapy for Medicare Patients with Common Cancers,"GROSS, CARY",YALE UNIVERSITY,CT,"$369,181"
Lung Cancer,2012,NIEHS,5R01ES008786-15,,Genotoxicity of Chromium Compounds,"ZHITKOVICH, ANATOLY",BROWN UNIVERSITY,RI,"$357,247"
Lung Cancer,2012,NCI,5R01CA148565-03,,PET Imaging of KRAS2 Activation to Guide EGFR Targeting in Cancer Therapy,"WICKSTROM, ERIC",THOMAS JEFFERSON UNIVERSITY,PA,"$563,160"
Lung Cancer,2012,NCI,5R01CA132580-05,,Inflammatory Cytokines Link NF-kappaB with Bim Degradation and Metastasis,"MAYO, MARTY",UNIVERSITY OF VIRGINIA,VA,"$276,110"
Lung Cancer,2012,NCI,7R01CA132844-04,,ROLE OF CYP24 IN NON-SMALL CELL LUNG CANCER,"HERSHBERGER, PAMELA",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$313,012"
Lung Cancer,2012,NCI,1R03CA159706-01A1,,An Inter-Personal Framework for Lung Cancer Decision-Making in African Americans,"LEE, SIMON",UNIV OF TX SW MED CTR-DALLAS,TX,"$79,375"
Lung Cancer,2012,NCI,5R21CA156000-02,,Repeat Biopsies in Lung Cancer to Define Targeted Resistance Mechanisms,"SEQUIST, LECIA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$230,985"
Lung Cancer,2012,NCI,5R03CA159707-02,,Intervention development for anxiety in advanced NSCLC patients and caregivers,"HENDRIKSEN, ELLEN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$88,500"
Lung Cancer,2012,NCI,5R01CA136635-04,,ROLE OF DNA METHYLTRANSFERASE 3B IN LUNG TUMORIGENESIS,"MAO, LI",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$301,913"
Lung Cancer,2012,NCI,5R01CA129610-05,,Mechanism and role of DLC-1 tumor suppressor loss in lung cancer,"DER, CHANNING",UNIVERSITY OF N CAROLINA AT CHAPEL HILL,NC,"$296,590"
Lung Cancer,2012,NCI,5R01CA129364-05,,Role of EGFR in DNA Repair and Radiation Response in Non Small Cell Lung Cancer,"NIRODI, CHAITANYA",UNIV OF TX SW MED CTR-DALLAS,TX,"$252,801"
Lung Cancer,2012,NCI,5R01CA140654-03,,The Role of Cul4A in Genome Stability and Cancer Development,"YOU, LIANG",UNIV OF CALIFORNIA AT SAN FRANCISCO,CA,"$292,368"
Lung Cancer,2012,NCI,5R01CA137195-04,,Characterization and drug targeting of the PML tumor suppressor in lung cancer,"SCAGLIONI, PIER",UNIV OF TX SW MED CTR-DALLAS,TX,"$316,002"
Lung Cancer,2012,NCI,5R01CA157510-02,,Mechanisms of chemotherapy response and tumor re-initiation in lung cancer,"SWEET-CORDERO, ERIC",STANFORD UNIVERSITY,CA,"$338,566"
Lung Cancer,2012,NCI,5R01CA136534-03,,Structure-based anti-cancer drug development,"DENG, XINGMING",EMORY UNIVERSITY,GA,"$309,976"
Lung Cancer,2012,NCI,5R01CA133253-03,,Lung cancer heterogeneity and its impact on drug resistance.,"ALTSCHULER, STEVEN",UNIV OF TX SW MED CTR-DALLAS,TX,"$453,829"
Lung Cancer,2012,NCI,5R01CA136765-04,,Genetic determinants associated with pemetrexed response and toxicity,"DOLAN, M",UNIVERSITY OF CHICAGO,IL,"$318,890"
Lung Cancer,2012,NIGMS,1SC1CA173069-01A1,,Anti-Tumorigenic Potential of Novel Digitoxin Analogues,"IYER, ANAND",HAMPTON UNIVERSITY,VA,"$297,384"
Lung Cancer,2012,NCI,5R01CA132552-05,,Lung tumor associated macrophages,"NIELD, LORI",UNIVERSITY OF COLORADO DENVER,CO,"$281,979"
Lung Cancer,2012,NCI,5R01CA136851-04,,EML4-ALK: A Potential Therapeutic Target in Lung Cancer,"JANNE, PASI",DANA-FARBER CANCER INSTITUTE,MA,"$332,392"
Lung Cancer,2012,NCI,5R01CA129534-05,,Biomarkers of NNK in prediction of lung cancer development in smokers,"YUAN, JIAN-MIN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$551,628"
Lung Cancer,2012,NCI,5R01CA119927-12,,Mechanism of Irradiation Pulmonary Fibrosis,"GREENBERGER, JOEL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$282,705"
Lung Cancer,2012,NIEHS,1R01ES021502-01,,FRESH: Dual Home Screening for Lung Cancer Prevention,"HAHN, ELLEN",UNIVERSITY OF KENTUCKY,KY,"$190,790"
Lung Cancer,2012,NIGMS,1R01ES021502-01,,FRESH: Dual Home Screening for Lung Cancer Prevention,"HAHN, ELLEN",UNIVERSITY OF KENTUCKY,KY,"$260,000"
Lung Cancer,2012,NCI,1R01CA166480-01,,Functional role of the MUC1-C oncoprotein in non-small cell lung cancer,"KUFE, DONALD",DANA-FARBER CANCER INSTITUTE,MA,"$534,201"
Lung Cancer,2012,NCI,5R01CA132847-04,,Role and mechanism of action of p62/Sqstm1 in Ras-induced tumorigenesis in lung,"MOSCAT, JORGE",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$394,064"
Lung Cancer,2012,NCI,1K99CA166186-01,,Real-Time Volumetric Imaging for Lung Cancer Radiotherapy,"LI, RUIJIANG",STANFORD UNIVERSITY,CA,"$160,621"
Lung Cancer,2012,NHLBI,5R01HL109265-02,,Mechanisms of Dicer1 Function in Lung Organogenesis and Cystic Lung Disease,"WIKENHEISER-BROKAMP, KATHRYN",CHILDREN'S HOSPITAL MEDICAL CENTER CINCI,OH,"$382,421"
Lung Cancer,2012,NHLBI,5R01HL107882-02,,Overlapping Airway Basal Cell Transcriptome Reprogramming in COPD and Lung Cancer,"CRYSTAL, RONALD",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$1,028,637"
Lung Cancer,2012,NCI,5R01CA075954-15,,Mechanism of Dnmt1 Up-regulation by Fhit Loss,"BRENNER, CHARLES",UNIVERSITY OF IOWA,IA,"$265,177"
Lung Cancer,2012,NIMHD,1R01MD005892-01A1,,Improving Resection Rates among African Americans with NSCLC,"FORD, MARVELLA",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$368,750"
Lung Cancer,2012,NCI,5R01CA149561-02,,"Flexible, Conformal, Polymeric Films for Lung Resection Margins","GRINSTAFF, MARK",BOSTON UNIVERSITY,MA,"$345,579"
Lung Cancer,2012,NCI,1U01CA157715-01A1,,Squamous Cell Carcinoma of the Lung: Validation of Molecular Signatures for Progn,"HIRSCH, FRED",UNIVERSITY OF COLORADO DENVER,CO,"$599,973"
Lung Cancer,2012,NCI,5K24CA139054-03,,"Risk for Lung Cancer, Asthma, and COPD; Integrating Clinical and Airway Biomarker","SPIVACK, SIMON",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$167,705"
Lung Cancer,2012,NCI,5R01CA135257-05,,Drug Resistance in Lung Cancer,"JANNE, PASI",DANA-FARBER CANCER INSTITUTE,MA,"$348,207"
Lung Cancer,2012,NHLBI,5R01HL108016-02,,Inherited genetic risk factors common to COPD and lung cancer.,"WILLEY, JAMES",UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS,OH,"$465,613"
Lung Cancer,2012,NCI,5R21CA156229-02,,Repair of tobacco carcinogens in the susceptibility of lung cancer,"SPRATT, THOMAS",PENNSYLVANIA STATE UNIVERSITY,PA,"$164,757"
Lung Cancer,2012,NIEHS,2R01ES015010-06A1,,The protective role of Nrf2 against arsenic-induced toxicity and carcinogenicity,"ZHANG, DONNA",UNIVERSITY OF ARIZONA,AZ,"$290,000"
Lung Cancer,2012,NCI,5R01CA092824-10,,Molecular and Genetic Analysis of Lung Cancer Survival,"CHRISTIANI, DAVID",HARVARD UNIVERSITY (SCH OF PUBLIC HLTH),MA,"$559,058"
Lung Cancer,2012,NIEHS,5R01ES009132-10,,Molecular mechanism of cytochrome P4501A1 expression.,"MOORTHY, BHAGAVATULA",BAYLOR COLLEGE OF MEDICINE,TX,"$353,925"
Lung Cancer,2012,NCI,5K23CA122182-05,,Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer,"NWOGU, CHUKWUMERE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$148,505"
Lung Cancer,2012,NCI,5R01CA081436-15,,Protein Kinase C Signaling Mechanisms in Cancer,"FIELDS, ALAN",MAYO CLINIC  JACKSONVILLE,FL,"$414,986"
Lung Cancer,2012,NCI,5R01CA096679-08,,LUNG TRAJECTORY MAPPING FOR RADIATION THERAPY,"LOW, DANIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$319,301"
Lung Cancer,2012,NCI,5U01CA084986-13,,Integrated Development of Novel Molecular Markers,"SIDRANSKY, DAVID",JOHNS HOPKINS UNIVERSITY,MD,"$355,600"
Lung Cancer,2012,NHLBI,5R01HL107883-02,,The Emphysematous Microenvironment Promotes Lung Tumorigenesis and Progression,"REILLY, JOHN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$712,065"
Lung Cancer,2012,NHLBI,5R01HL107612-02,,Common Pathogenetic Mechanisms of Lung Cancer and COPD,"WENDT, CHRIS",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$726,338"
Lung Cancer,2012,NIEHS,1R15ES021587-01,,The Synergistic effect and Mechanism of Arsenic on Chromium (VI) Carcinogenesis,"XIE, HONG",UNIVERSITY OF SOUTHERN MAINE,ME,"$414,961"
Lung Cancer,2012,NCI,5R01CA095039-09,,Sequence distribution of tobacco carcinogen-DNA adducts,"TRETYAKOVA, NATALIA",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$206,571"
Lung Cancer,2012,NCI,5R01CA126939-05,,The Epidemiology of Molecular Alterations in Mesothelioma,"KELSEY, KARL",BROWN UNIVERSITY,RI,"$470,931"
Lung Cancer,2012,NIGMS,2R56LM009500-04,,A Novel Computational Framework for individualized clinical decision-making,"GUO, NANCY",WEST VIRGINIA UNIVERSITY,WV,"$260,000"
Lung Cancer,2012,NCI,2P01CA066726-15A1,5805,Clinical Trials in Mesothelioma,"STERMAN, DANIEL",UNIVERSITY OF PENNSYLVANIA,PA,"$302,808"
Lung Cancer,2012,NCI,1R01CA160522-01A1,,Therapeutic potential of mTOR kinase inhibitors in lung cancer,"SUN, SHI-YONG",EMORY UNIVERSITY,GA,"$321,625"
Lung Cancer,2012,NCI,5R01CA116812-06,,Lung extracellular matrix and tumor progression,"ROMAN, JESSE",UNIVERSITY OF LOUISVILLE,KY,"$299,900"
Lung Cancer,2012,NIEHS,5R01ES015262-05,,Genetic and Epigenetic Biomarkers for SCC of the Lung,"BELINSKY, STEVEN",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$677,372"
Lung Cancer,2012,NCI,5U01CA152751-03,,The UCLA - Boston University Lung Cancer Biomarker Development Laboratory,"DUBINETT, STEVEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$647,222"
Lung Cancer,2012,NCI,5R01CA097356-08,,Factors for Epigenetic Silencing of Lung Cancer Genes,"BELINSKY, STEVEN",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$968,202"
Lung Cancer,2012,NHLBI,5R01HL098686-03,,Model-Based Image Reconstruction for X-ray CT in Lung Imaging,"FESSLER, JEFFREY",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$592,336"
Lung Cancer,2012,NCI,5K08CA154784-02,,The role of Nkx2-1 in lung adenocarcinoma,"SNYDER, ERIC",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$179,280"
Lung Cancer,2012,NCI,5R01CA140594-04,,Inhibition of P13k and MEK Pathways in the Treatment of Lung Cancer,"WONG, KWOK KIN",DANA-FARBER CANCER INSTITUTE,MA,"$496,412"
Lung Cancer,2012,NCI,2R01CA092025-11,,Benzo[a]pyrene metabolism: phenotyping and genotyping,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$334,995"
Lung Cancer,2012,NCI,5R01CA136705-04,,Epigenetic and post-translational regulation of the metastasis suppressor BRMS1,"JONES, DAVID",UNIVERSITY OF VIRGINIA,VA,"$304,932"
Lung Cancer,2012,NCI,5R01CA033616-31,,Apoptosis Regulation by Adenovirus and Cellular Genes,"CHINNADURAI, GOVINDASWAMY",SAINT LOUIS UNIVERSITY,MO,"$288,011"
Lung Cancer,2012,NCI,5R21CA163010-02,,Synthetic cannabinoids as novel therapeutic strategies against non-small cell lun,"GANJU, RAMESH",OHIO STATE UNIVERSITY,OH,"$165,844"
Lung Cancer,2012,NIEHS,5F30ES017730-04,,Y-family DNA polymerases and cellular responses to benzo[a]pyrene,"KLARER, ALDEN",UNIVERSITY OF LOUISVILLE,KY,"$41,666"
Lung Cancer,2012,NIEHS,1R01ES020357-01A1,,Mitigation of asbestos induced alveolar epithelial cell injury,"KAMP, DAVID",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$329,621"
Lung Cancer,2012,NCI,1U43CA167593-01,,Production and Evaluation of a Vault-CCL21 Nanocapsule as a Lung Cancer Treatment,"BUCHMAN, GEORGE",CHESAPEAKE PERL,MD,"$157,915"
Lung Cancer,2012,NCI,5R01CA142724-03,,Role of Foxm1 in Lung Cancer Microenvironment,"KALIN, TANYA",CHILDREN'S HOSPITAL MEDICAL CENTER CINCI,OH,"$307,951"
Lung Cancer,2012,NCI,5R01CA142840-03,,Functional Image and Molecular Marker to Individualize Adaptive Radiation Dose Es,"KONG, FENG-MING",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$412,123"
Lung Cancer,2012,NCI,5R01CA134682-05,,Genome-Wide Association Studies of Inherited Predisposition to Lung Cancer,"YOU, MING",MEDICAL COLLEGE OF WISCONSIN,WI,"$448,167"
Lung Cancer,2012,NCI,5U24CA086366-13,,The Early Detection Research Network Biomarker Resource Laboratory at UCLA,"CHIA, DAVID",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$379,129"
Lung Cancer,2012,NIGMS,2R01GM067193-09A1,,Eukaryotic Post-Translational Modifications,"KELLEHER, NEIL",NORTHWESTERN UNIVERSITY,IL,"$328,795"
Lung Cancer,2012,NCI,2R01CA116020-06,,Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma,"ECK, MICHAEL",DANA-FARBER CANCER INSTITUTE,MA,"$326,813"
Lung Cancer,2012,NCI,5R21CA156068-02,,Lung Sparing for SBRT with beam's-eye-view images and real time tumor tracking,"BERBECO, ROSS",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$197,100"
Lung Cancer,2012,NCI,5R03CA162546-02,,Endocrine Targets for Prevention of Lung Cancer,"BIGSBY, ROBERT",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$77,000"
Lung Cancer,2012,NCI,5R01CA131217-04,,Nonpeptide macrocyclic histone deacetylase (HDAC) inhibitors for targeted lung ca,"OYELERE, ADEGBOYEGA",GEORGIA INSTITUTE OF TECHNOLOGY,GA,"$292,322"
Lung Cancer,2012,NCI,5R21CA161590-02,,Predictive biomarker development in lung cancer: ROS1 chromosomal rearrangements,"IAFRATE, ANTHONY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$192,488"
Lung Cancer,2012,NCI,5R21CA153000-02,,Combined PKCiota and mTOR inhibition for treatment of advanced squamous lung canc,"FIELDS, ALAN",MAYO CLINIC  JACKSONVILLE,FL,"$327,704"
Lung Cancer,2012,NCI,5R01CA135405-05,,Transition State Analogues as Modulators of DNA Methylation,"SCHRAMM, VERN",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$261,900"
Lung Cancer,2012,NCI,2P01CA042063-26A1,6429,Investigation of Regulatory RNAs in Tumor Development,"JACKS, TYLER",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$267,154"
Lung Cancer,2012,NCI,2P01CA042063-26A1,6430,Cancer and Gene Regulation by the pRB/E2F Pathway,"LEES, JACQUELINE",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$238,438"
Lung Cancer,2012,NCI,5R01CA118762-07,,SAG E3 ubiquitin ligase in regulation of transformation and carcinogenesis,"SUN, YI",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$268,009"
Lung Cancer,2012,NCI,5R01CA100816-08,,Novel Strategy for Lung Cancer Treatment Using IGF-1R Inhibitor,"LEE, HO-YOUNG",SEOUL NATIONAL UNIVERSITY,KOR R,"$171,049"
Lung Cancer,2012,NCI,2R01CA123067-06A1,,Mitochondrial Metabolism and ROS Regulate Lung Cancer,"CHANDEL, NAVDEEP",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$281,862"
Lung Cancer,2012,NCI,7R01CA127547-05,,Identification and characterization of driver gene(s) in recurrent lung cancer am,"MU, DAVID",EASTERN VIRGINIA MEDICAL SCHOOL,VA,"$265,382"
Lung Cancer,2012,NCI,5R01CA138624-04,,Phase III Trial of Exercise Training in Postsurgical Lung Cancer,"JONES, LEE",DUKE UNIVERSITY,NC,"$400,379"
Lung Cancer,2012,NCI,5R01CA140550-03,,"SIAH2-Dependent Proteolysis in Cell Migration, Tumor Growth and Cancer Metastasis","TANG, AMY",EASTERN VIRGINIA MEDICAL SCHOOL,VA,"$288,830"
Lung Cancer,2012,NCI,5K23CA149079-02,,Inhibiting EGFR and ER pathways in NSCLC,"GARON, EDWARD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$165,240"
Lung Cancer,2012,NHLBI,7R01HL108979-02,,"""Neutrophil Elastase Links Idiopathic Pulmonary Fibrosis and Lung Cancer""","HOUGHTON, A. MCGARRY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$428,600"
Lung Cancer,2012,NCI,1R21CA161670-01A1,,A mechanistic model to derive lung tumor motion from whole surface tracking,"SHENG, KE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$133,980"
Lung Cancer,2012,NCI,1R01CA161585-01A1,,Targeting Galectin-1 with radiation in lung cancer,"LE, QUYNH-THU",STANFORD UNIVERSITY,CA,"$326,810"
Lung Cancer,2012,NCI,5R01CA138256-05,,Comparative functional genomics for lung cancer gene discovery,"SWEET-CORDERO, ERIC",STANFORD UNIVERSITY,CA,"$521,052"
Lung Cancer,2012,NCI,5R03CA162520-02,,Bionanoconjugates for Detection of Circulating Tumor Cells in Lung Cancer,"HIRSCHOWITZ, EDWARD",UNIVERSITY OF KENTUCKY,KY,"$74,250"
Lung Cancer,2012,NCI,5R01CA127636-06,,Impact of BRG1 Loss in Lung Cancer Development,"REISMAN, DAVID",UNIVERSITY OF FLORIDA,FL,"$270,000"
Lung Cancer,2012,NCI,1R21CA161561-01A1,,Biomarkers for Epigenetic Therapy of Lung Cancer,"TESSEMA, MATHEWOS",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$222,929"
Lung Cancer,2012,NCI,1U01CA161045-01A1,,Exome Sequencing to identify Novel Genetic Factors for Lung Cancer in Nonsmokers,"CAI, QIUYIN",VANDERBILT UNIVERSITY MED CTR,TN,"$639,441"
Lung Cancer,2012,NCI,5U01CA152662-03,,Validation of Biomarkers of Risk for the Early Detection of Lung Cancer,"MASSION, PIERRE",VANDERBILT UNIVERSITY MED CTR,TN,"$654,948"
Lung Cancer,2012,OD,5R01CA142649-03,,Developing a Post-carcinogen Lung Cancer Chemopreventive Agent,"XING, CHENGGUO",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$200,000"
Lung Cancer,2012,NCI,5K07CA125203-05,,Exploring Common Linkage Regions in Lung Cancer and COPD,"COTE, MICHELE",WAYNE STATE UNIVERSITY,MI,"$132,921"
Lung Cancer,2012,NCI,1R03CA167721-01,,CYP1B1:  A Molecular Target for Chemoprevention of Lung Adenocarcinoma,"CLAPPER, MARGIE",INSTITUTE FOR CANCER RESEARCH,PA,"$89,250"
Lung Cancer,2012,NHLBI,1R01HL112212-01A1,,Reducing Environmental Tobacco Smoke Exposure in Public Housing,"LEVY, DOUGLAS",MASSACHUSETTS GENERAL HOSPITAL,MA,"$790,181"
Lung Cancer,2012,NCI,5R01CA154314-02,,Regulation of caspase 9 RNA splicing in NSCLC cancer,"CHALFANT, CHARLES",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$310,213"
Lung Cancer,2012,NLM,1R01LM011333-01,,RUMI: A patient portal for retrieving understandable medical information,"BUI, ALEX",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$332,548"
Lung Cancer,2012,NIBIB,5R37EB000244-33,,Controlled Release of Macromolecules,"LANGER, ROBERT",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$399,667"
Lung Cancer,2012,NCI,5R21CA156087-02,,Peripheral Blood Gene Expression for the Diagnosis of Indeterminate Lung Nodules,"VACHANI, ANIL",UNIVERSITY OF PENNSYLVANIA,PA,"$181,039"
Lung Cancer,2012,NCI,5R01CA133470-05,,Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy,"CHRISTOFIDOU-SOLOMIDOU, MELPO",UNIVERSITY OF PENNSYLVANIA,PA,"$317,009"
Lung Cancer,2012,NCI,5R01CA092596-09,,Human CYP2A and respiratory tract xenobiotic toxicity,"DING, XINXIN",WADSWORTH CENTER,NY,"$321,548"
Lung Cancer,2012,NCI,5U24CA115091-08,,"University of Maryland, Baltimore Biomarker Reference Laboratory","STASS, SANFORD",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$401,644"
Lung Cancer,2012,NCI,5R21CA143549-02,,Carboxylesterase-activated Doxazolidine-prodrug for Hepatocellular Carcinoma,"KOCH, TAD",UNIVERSITY OF COLORADO AT BOULDER,CO,"$164,756"
Lung Cancer,2012,NCI,5K08CA160658-02,,"""Comparative gene resequencing in mouse cancer models""","MCFADDEN, DAVID",MASSACHUSETTS GENERAL HOSPITAL,MA,"$180,360"
Lung Cancer,2012,NCI,5R01CA160715-02,,The Role of HMGB1 in the Pathogenesis of Mesothelioma,"YANG, HAINING",UNIVERSITY OF HAWAII AT MANOA,HI,"$311,250"
Lung Cancer,2012,NCI,5R01CA139959-04,,CHEMOPREVENTION OF LUNG SQUAMOUS CELL CARCINOMA WITH POLYPHENON E,"WANG, YIAN",WASHINGTON UNIVERSITY,MO,"$232,218"
Lung Cancer,2012,OD,5R01CA139959-04,,CHEMOPREVENTION OF LUNG SQUAMOUS CELL CARCINOMA WITH POLYPHENON E,"WANG, YIAN",WASHINGTON UNIVERSITY,MO,"$76,000"
Lung Cancer,2012,NIEHS,5F30ES019464-03,,Suppression of Lung Cancer Growth by Ceramide,"SADDOUGHI, SAHAR",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$39,877"
Lung Cancer,2012,NCI,5U01CA151452-03,,COMBINATORIAL-DESIGNED NANO-PLATFORMS TO OVERCOME TUMOR DRUG RESISTANCE,"AMIJI, MANSOOR",NORTHEASTERN UNIVERSITY,MA,"$413,032"
Lung Cancer,2012,NIA,5K08AG031583-05,,Continuity of care and end of the life ICU use,"SHARMA, GULSHAN",UNIVERSITY OF TEXAS MEDICAL BR GALVESTON,TX,"$119,610"
Lung Cancer,2012,NCI,1R43CA167853-01,,Therapeutic antibody to radiation inducible TIP1 activates immune effector cells,"MICHENER, MARSHALL","RADTARGX THERAPEUTICS, INC.",MO,"$278,123"
Lung Cancer,2012,NCI,5F32CA154237-03,,Lung cancer initiating cells in a tumor mouse model deficient in Cdkn2ab,"SCHUSTER, KATJA",UNIV OF TX SW MED CTR-DALLAS,TX,"$57,734"
Lung Cancer,2012,NCI,5K23CA131577-04,,Gene Modified Dendritic Cell Therapy in Lung Cancer,"LEE, JAY",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$132,031"
Lung Cancer,2012,NCI,5K24CA128953-05,,Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer,"ANTONIA, SCOTT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$171,205"
Lung Cancer,2012,NCI,1F31CA167878-01,,Targeting EphA2 in Tyrosine Kinase Inhibitor Resistant Lung Cancer,"AMATO, KATHERINE",VANDERBILT UNIVERSITY MED CTR,TN,"$26,849"
Lung Cancer,2012,NCI,1R43CA167865-01,,Development of novel targeted agents in lung cancer,"SIGALOV, ALEXANDER","SIGNABLOK, INC.",MA,"$221,738"
Lung Cancer,2012,NCI,5U10CA149950-02,,ACOSOG Community Clinical Oncology Program (CCOP) Research Base,"SLOAN, JEFF",MAYO CLINIC,MN,"$1,474,780"
Lung Cancer,2012,NCI,5U01CA086137-13,,NYU Lung Cancer Biomarker Center,"ROM, WILLIAM",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$895,726"
Lung Cancer,2012,NCI,5R00CA134920-05,,Optical Imaging of the Pulmonary Airways in the Assessment of Lung Cancer,"SUTER, MELISSA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$241,531"
Lung Cancer,2012,NCI,1R43CA162629-01A1,,Targeted Therapy for Non Small Cell Lung Carcinoma: In vivo Feasibility Studies,"SERRERO, GINETTE","A AND G PHARMACEUTICAL, INC.",MD,"$193,879"
Lung Cancer,2012,NCI,5R01CA164782-02,,Epigenetic Changes Link COPD and Lung Cancer,"TESFAIGZI, YOHANNES",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$807,435"
Lung Cancer,2012,NCI,5K08CA137170-04,,Role of Bronchioalveolar Stem Cells in Tissue Repair and Lung Adenocarcinomas,"KUMAR, ATUL",STANFORD UNIVERSITY,CA,"$151,349"
Lung Cancer,2012,NINR,1F31NR013114-01A1,,Symptom Experience Following Lung Cancer Surgery,"HOPKINS, KATHLEEN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$42,232"
Lung Cancer,2012,NCI,1F32CA157197-01A1,,Array of Resistive Sensors for Detecting Lung Cancer in Exhaled Air,"MIRICA, KATHERINE",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$47,114"
Lung Cancer,2012,NCI,1F32CA168112-01,,The role of Vimentin in cell adhesion and lung cancer metastasis,"HAVEL, LAUREN",EMORY UNIVERSITY,GA,"$47,114"
Lung Cancer,2012,NCI,5F31CA159614-02,,Impact of uracil DNA glycosylase on lung cancer cell sensitivity to pemetrexed,"WEEKS, LACHELLE",CASE WESTERN RESERVE UNIVERSITY,OH,"$47,232"
Lung Cancer,2012,NCI,5R01CA151989-02,,Telomeres and lung cancer incidence and survival,"DOHERTY, JENNIFER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$703,025"
Lung Cancer,2012,NCI,5U01CA111295-06,,The North American Mesothelioma Consortium,"PASS, HARVEY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$579,019"
Lung Cancer,2012,NCI,5F32CA162681-02,,Identifying novel p53 target genes that mediate tumor suppression,"BIEGING, KATHRYN",STANFORD UNIVERSITY,CA,"$52,190"
Lung Cancer,2012,NCI,1F32CA168330-01,,Role of Ascl1 in glioma,"VUE, TOU YIA",UNIV OF TX SW MED CTR-DALLAS,TX,"$49,214"
Lung Cancer,2012,NIEHS,5R01ES020425-02,,Validation of a Genomic Biomarker of Response to Environmental Tobacco Smoke,"SPIRA, AVRUM",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$487,236"
Lung Cancer,2012,NCI,5R01CA104397-09,,Role of IKK in NSCLC: Modulation of SMRT and NF-kappaB,"MAYO, MARTY",UNIVERSITY OF VIRGINIA,VA,"$270,040"
Lung Cancer,2012,NCI,5R00CA131477-05,,UDP-glucuronosyltransferase genes and gender-differences in lung cancer risk,"GALLAGHER, CARLA",PENNSYLVANIA STATE UNIVERSITY,PA,"$241,530"
Lung Cancer,2012,NCI,5R44CA121612-05,,New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells,"AUNG, SANDRA","UBIVAC, LLC",OR,"$648,309"
Lung Cancer,2012,NCI,5K07CA138772-05,,Improving decisions about evaluating pulmonary nodules for lung cancer,"WIENER, RENDA",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$169,236"
Lung Cancer,2012,NCI,5R01CA154377-02,,Investigation of an anti-cancer phytochemical targeting Nrf2,"ZHANG, DONNA",UNIVERSITY OF ARIZONA,AZ,"$309,251"
Lung Cancer,2012,NCI,5R01CA164780-02,,Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer,"GERACI, MARK",UNIVERSITY OF COLORADO DENVER,CO,"$601,421"
Lung Cancer,2012,NCI,5K08CA131483-05,,TGFbeta and lung squamous cell carcinoma,"MALKOSKI, STEPHEN",UNIVERSITY OF COLORADO DENVER,CO,"$136,900"
Lung Cancer,2012,NCI,5R00CA151672-03,,Cancer gene discovery using Sleeping Beauty transposon-mediated mutagenesis,"STARR, TIMOTHY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$241,529"
Lung Cancer,2012,NCI,5K01CA128887-04,,The Role of MicroRNAs in Controlling Fibroblast Proliferation and Tumor Promotion,"LEGESSE-MILLER, ASTER",PRINCETON UNIVERSITY,NJ,"$177,444"
Lung Cancer,2012,NIBIB,8R21EB015907-03,,Resolution Limits for Fluorescence Tomographic Molecular Imaging,"ZHANG, XIAOFENG",DUKE UNIVERSITY,NC,"$193,000"
Lung Cancer,2012,NIGMS,5SC1CA161676-02,,Targeted Nanocarriers for Treatment of Lung Cancer,"SACHDEVA, MANDIP",FLORIDA AGRICULTURAL AND MECHANICAL UNIV,FL,"$292,000"
Lung Cancer,2012,NCI,5R01CA133539-04,,Radiotherapy with Dose-Rate Regulated Tracking,"YI, BYONGYONG",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$319,884"
Lung Cancer,2012,NCCAM,5F31AT006487-02,,"The effects of 1,25(OH)2D3 on the tumorigenesis of lung squamous cell carcinoma","MAZZILLI, SARAH",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$14,078"
Lung Cancer,2012,OD,5F31AT006487-02,,"The effects of 1,25(OH)2D3 on the tumorigenesis of lung squamous cell carcinoma","MAZZILLI, SARAH",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$13,645"
Lung Cancer,2012,NCI,5R01CA143597-03,,Serum Levels of EGFR-Signaling-Network Activators/Inhibitor and Lung Cancer Risk,"HO, GLORIA",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$560,055"
Lung Cancer,2012,NCI,5F31CA157150-03,,Fhit as modulator of Chk1 termination and response to DNA-damaging agents,"SALDIVAR, JOSHUA",OHIO STATE UNIVERSITY,OH,"$29,351"
Lung Cancer,2012,NCI,5K08CA151649-03,,Dissection of microRNA-21s role in non-small cell lung cancer,"HATLEY, MARK",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$168,480"
Lung Cancer,2012,NCI,1U01CA168409-01,,COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS,"POWERS, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$1,405,573"
Lung Cancer,2012,NCI,5R01CA152099-02,,Inflammation and Immunosuppression in Lung Cancer,"YAN, CONG",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$309,328"
Lung Cancer,2012,NCI,5U01CA152956-03,,Comparative Modeling of Lung Cancer Control Policies,"MCMAHON, PAMELA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$1,353,662"
Lung Cancer,2012,NCI,5R01CA161837-02,,Non-invasive Biomarker Panels for Early Detection of Lung Squamous Cell Carcinoma,"JIANG, FENG",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$379,913"
Lung Cancer,2012,NCCAM,5R01AT005522-04,,Chemoprevention of lung cancer with red ginseng extracts,"YOU, MING",MEDICAL COLLEGE OF WISCONSIN,WI,"$218,045"
Lung Cancer,2012,OD,5R01AT005522-04,,Chemoprevention of lung cancer with red ginseng extracts,"YOU, MING",MEDICAL COLLEGE OF WISCONSIN,WI,"$200,000"
Lung Cancer,2012,NCI,5K05CA092002-09,,Mentoring and Research in Cancer Epidemiology,"WEISS, NOEL",UNIVERSITY OF WASHINGTON,WA,"$156,254"
Lung Cancer,2012,NCI,5K08CA151651-03,,MicroRNA-200 family regulation by the apical-basal polarity complexes in EMT and,"GIBBONS, DON",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$170,640"
Lung Cancer,2012,NCI,5R21CA162178-02,,PROTEIN PROTEIN INTERACTIONS AS BIOMARKERS,"HAURA, ERIC",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$181,613"
Lung Cancer,2012,NCI,5R00CA131488-05,,Mechanisms of Mutant Epidermal Growth Factor Receptor Induced Lung Tumorigenesis,"POLITI, KATERINA",YALE UNIVERSITY,CT,"$241,530"
Lung Cancer,2012,NCI,5R01CA155260-02,,Translational phosphoproteomics for lung cancer,"GERBER, SCOTT",DARTMOUTH COLLEGE,NH,"$327,850"
Lung Cancer,2012,NCI,5R01CA141769-02,,Inflammation Pathways and COPD in the Development of Lung Cancer,"SCHWARTZ, ANN",WAYNE STATE UNIVERSITY,MI,"$1,738,264"
Lung Cancer,2012,NCI,5K23CA149076-02,,MicroRNA profiling to predict recurrence after resection of early lung cancer,"YENDAMURI, SAIKRISHNA",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$187,965"
Lung Cancer,2012,NIDA,5R01DA026815-02,,Socioeconomic status and smoking exposure in Appalachia,"MUSCAT, JOSHUA",PENNSYLVANIA STATE UNIVERSITY,PA,"$287,370"
Lung Cancer,2012,NCI,5U01CA141576-04,,LKB1 tumor suppressor and human cancer,"CASTRILLON, DIEGO",UNIV OF TX SW MED CTR-DALLAS,TX,"$793,787"
Lung Cancer,2012,NCI,5R44CA123994-06,,PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm,"GILLESPIE, JOHN","20/20 GENESYSTEMS, INC.",MD,"$980,392"
Lung Cancer,2012,NIDA,5R21DA031966-02,,Evaluation of harmful effects of cannabis smoke on vascular endothelial function,"SPRINGER, MATTHEW",UNIV OF CALIFORNIA AT SAN FRANCISCO,CA,"$193,125"
Lung Cancer,2012,NCI,5R01CA160251-02,,Tools for Linking and Mining image and Genomic Data in Non-Small Cell Lung Cancer,"NAPEL, SANDY",STANFORD UNIVERSITY,CA,"$596,190"
Lung Cancer,2012,NCI,5R01CA120528-07,,Validation of Prognostic and Diagnostic Molecular Tests in Mesothelioma,"BUENO, RAPHAEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$344,704"
Lung Cancer,2012,NCI,5R01CA122794-07,,In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap,"WONG, KWOK KIN",DANA-FARBER CANCER INSTITUTE,MA,"$282,228"
Lung Cancer,2012,NIGMS,5R01GM097478-02,,Structure-Based Design of Xe-129 NMR Biosensors for Multiplexed Cancer Detection,"DMOCHOWSKI, IVAN",UNIVERSITY OF PENNSYLVANIA,PA,"$414,699"
Lung Cancer,2012,NCI,5R01CA155196-02,,Personalizing NSCLC Therapy: Exploiting KRAS activated pathways,"HERBST, ROY",YALE UNIVERSITY,CT,"$564,855"
Lung Cancer,2012,NCI,5R21CA161182-02,,Using Ketogenic Diets to Enhance Radio-Chemo-Therapy Response: A Phase I Trial,"SPITZ, DOUGLAS",UNIVERSITY OF IOWA,IA,"$153,590"
Lung Cancer,2012,NCI,5R01CA164783-02,,Molecular biomarkers of airway and lung linking COPD and Lung Cancer,"SPIRA, AVRUM",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$535,797"
Lung Cancer,2012,NCI,5R21CA155518-02,,Soy isoflavones to augment radiotherapy of lung carcinoma,"HILLMAN, GILDA",WAYNE STATE UNIVERSITY,MI,"$157,700"
Lung Cancer,2012,NCI,5K23CA157631-02,,CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation,"NISHINO, MIZUKI",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$180,360"
Lung Cancer,2012,NCI,5F31CA159821-02,,Elucidating the Molecular Mechanisms of Ect2 in cytokinesis and oncogenesis,"COOK, DANIELLE",UNIVERSITY OF N CAROLINA AT CHAPEL HILL,NC,"$41,267"
Lung Cancer,2012,RMAP,5R01CA163255-02,,Succinylation and Malonylation as Novel Protein Modifications in Cancer,"LIN, HENING",CORNELL UNIVERSITY,NY,"$584,640"
Lung Cancer,2012,NCI,5K08CA154787-02,,Genetic Modifiers such as Fas Regulate Tumor-Cell Dependence on Mutant EGFR,"BIVONA, TREVER",UNIV OF CALIFORNIA AT SAN FRANCISCO,CA,"$168,480"
Lung Cancer,2012,NCI,5K08CA158425-02,,Assessing the Notch Pathway as a Therapeutic Target in Lung Cancer Adenocarcinoma,"HASSAN, KHALED",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$174,800"
Lung Cancer,2012,NCI,5R01CA138528-03,,Role of the noncanonical WNT pathway in non-small cell lung cancer,"WINN, ROBERT",UNIVERSITY OF COLORADO DENVER,CO,"$299,803"
Lung Cancer,2012,NCI,5U01CA155340-02,,One-carbon metabolism biomarkers and lung cancer risk,"BRENNAN, PAUL",INTERNATIONAL AGENCY FOR RES ON CANCER,FR,"$1,665,211"
Lung Cancer,2012,NCI,5U01CA154969-02,,Clinically-Relevant Regulatory Networks in the Lung Tumor Microenvironment,"PLEVRITIS, SYLVIA",STANFORD UNIVERSITY,CA,"$588,516"
Lung Cancer,2012,NCI,5R42CA141907-03,,Broncho-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma,"SEWARD, KIRK","MERCATOR MEDSYSTEMS, INC.",CA,"$463,075"
Lung Cancer,2012,RMAP,5R01CA163256-02,,Contrast-Enhanced and Image-Guided Surgery of Lung Cancer,"NIE, SHUMING",EMORY UNIVERSITY,GA,"$1,323,836"
Lung Cancer,2012,NCI,6R44CA135967-03,,Prevention of Tumor Recurrence Following Surgical Resection (Phase II),"WOLINSKY, JESSE",ACUITYBIO CORPORATION,MA,"$498,107"
Lung Cancer,2012,NCI,5R01CA155284-02,,Optical Nanoscale Analysis of Buccal Cells: Transforming Lung Cancer Screening,"BACKMAN, VADIM",NORTHWESTERN UNIVERSITY,IL,"$590,916"
Lung Cancer,2012,NCI,5R01CA157850-02,,Rationally designed targeted therapeutic approaches for NSCLC,"DEGREGORI, JAMES",UNIVERSITY OF COLORADO DENVER,CO,"$304,278"
Lung Cancer,2012,NCI,5K23CA164015-02,,Novel systemic therapy to improve clinical outcome in small cell lung cancer,"OWONIKOKO, TAOFEEK",EMORY UNIVERSITY,GA,"$163,298"
Lung Cancer,2012,NIGMS,5K25GM093233-02,,Low Cost Diagnosis of Disease using Synthetic DNA Reactions,"HUGHES, WILLIAM",BOISE STATE UNIVERSITY,ID,"$137,700"
Lung Cancer,2012,NCI,1U01CA168878-01,,Extracellular Sulfatases As Novel Biomarkers For Early Detection of Cancer,"LEMJABBAR-ALAOUI, HASSAN",UNIV OF CALIFORNIA AT SAN FRANCISCO,CA,"$452,035"
Lung Cancer,2012,NCI,1DP2CA174497-01,,Discovery of Rational Companion Therapeutic Targets to Optimize Cancer Treatment,"BIVONA, TREVER",UNIV OF CALIFORNIA AT SAN FRANCISCO,CA,"$2,348,750"
Lung Cancer,2012,NCI,1K99CA169512-01,,Investigating microRNA miR-34a in lung cancer development and therapy,"XUE, WEN",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$110,355"
Lung Cancer,2012,NIMHD,1P20MD006881-01,6380,Determinants and Consequences of Second-hand Smoke Exposure in African American,"DAVIS, SHARON",MOREHOUSE SCHOOL OF MEDICINE,GA,"$173,135"
Lung Cancer,2012,NIMHD,1P20MD006738-01,6474,Targeted Nanocarrier Combination Based Therapy for Lung Cancer,"SACHDEVA, MANDIP",FLORIDA AGRICULTURAL AND MECHANICAL UNIV,FL,"$164,845"
Lung Cancer,2012,NIMHD,1P20MD006738-01,6539,Research Core,"SACHDEVA, MANDIP",FLORIDA AGRICULTURAL AND MECHANICAL UNIV,FL,"$164,844"
Lung Cancer,2012,NCI,1R15CA161491-01A1,,Capsaicin and Small cell Lung Cancer Therapy,"DASGUPTA, PIYALI",MARSHALL UNIVERSITY,WV,"$426,000"
Lung Cancer,2012,NIEHS,1R01ES021100-01A1,,Arsenic co-carcinogenesis with UVR: nitrosation and oxidation of target proteins,"LIU, KE",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$339,750"
Lung Cancer,2012,NIEHS,1R01ES020137-01A1,,MicroRNA-190 and Oxidative Stress in Arsenic carcinogenesis,"CHEN, FEI",WAYNE STATE UNIVERSITY,MI,"$350,402"
Lung Cancer,2012,NHLBI,1R01HL111190-01A1,,FGF9 REGULATION OF LUNG DEVELOPMENT AND PATHOGENESIS OF PLEUROPULMONARY BLASTOMA,"ORNITZ, DAVID",WASHINGTON UNIVERSITY,MO,"$520,732"
Lung Cancer,2012,NCI,1R01CA162433-01A1,,The P450 Epoxygenases as Pro-Oncogenic Enzymes,"POZZI, AMBRA",VANDERBILT UNIVERSITY MED CTR,TN,"$336,781"
Lung Cancer,2012,NIGMS,1R01GM100387-01A1,,Transfer Rule Learning for Knowledge Based Biomarker Discovery and Predictive Bio,"GOPALAKRISHNAN, VANATHI",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$299,716"
Lung Cancer,2012,NCI,2R01CA129562-03A1,,"Novel effectors of Kras in oncogenesis, senescence and tumor progression","SWEET-CORDERO, ERIC",STANFORD UNIVERSITY,CA,"$269,988"
Lung Cancer,2012,NCI,2R01CA114465-06A1,,EGFR Mutations in Non-Small Cell Lung Cancer,"JOHNSON, BRUCE",DANA-FARBER CANCER INSTITUTE,MA,"$495,415"
Lung Cancer,2012,NCI,1R01CA164447-01A1,,A Suite of Tumor Targeting Peptides for Personalized Therapy of Lung Cancer,"BROWN, KATHLYNN",UNIV OF TX SW MED CTR-DALLAS,TX,"$313,615"
Lung Cancer,2012,NCI,2R01CA111834-06A1,,The role of the Kras4A isoform in epithelial carcinogenesis,"BALMAIN, ALLAN",UNIV OF CALIFORNIA AT SAN FRANCISCO,CA,"$269,732"
Lung Cancer,2012,NCI,5P50CA058184-17,8042,P1:  Epigenetic Staging and Therapy for Lung Cancers,"HERMAN, JAMES",JOHNS HOPKINS UNIVERSITY,MD,"$305,382"
Lung Cancer,2012,NCI,5P50CA058184-17,8044,P2:  Gene Promoter Hypermethylation as a Biomarker for Lung Cancer Detection,"BELINSKY, STEVEN",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$437,060"
Lung Cancer,2012,NCI,5P50CA058184-17,8045,P3:  Deregulated NRF2-KEAP1 Pathway as a Critical Regulator of Chemoresistance,"BISWAL, SHYAM",JOHNS HOPKINS UNIVERSITY,MD,"$207,145"
Lung Cancer,2012,NCI,5P50CA058184-17,8046,P4:  Inhibition of Fatty Acid Synthase for Lung Cancer Treatment,"GABRIELSON, EDWARD",JOHNS HOPKINS UNIVERSITY,MD,"$122,752"
Lung Cancer,2012,NCI,5P50CA058184-17,8049,CA:  Administrative Core,"BAYLIN, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$79,306"
Lung Cancer,2012,NCI,5P50CA058184-17,8050,CB:  Human Tissue and Pathology,"GABRIELSON, EDWARD",JOHNS HOPKINS UNIVERSITY,MD,"$210,777"
Lung Cancer,2012,NCI,5P50CA058184-17,8052,CC:  Statistical Core,"GOODMAN, STEVEN",JOHNS HOPKINS UNIVERSITY,MD,"$81,553"
Lung Cancer,2012,NCI,5P50CA058184-17,8054,Development Research Program,"BAYLIN, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$214,072"
Lung Cancer,2012,NCI,5P50CA058184-17,8058,Career Development Program,"BAYLIN, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$66,953"
Lung Cancer,2012,NCI,5P30CA077598-14,5746,Carcinogenesis & Chemoprevention,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$24,283"
Lung Cancer,2012,NIEHS,5P20ES018169-03,5327,"Project 3: Human Fetal Lung, Arsenic Exposure,  Tissue Remodeling","DEPAEPE, MONIQUE",BROWN UNIVERSITY,RI,"$44,128"
Lung Cancer,2012,NIEHS,5P42ES013660-08,6031,Project 4: Biological Dosimetry of Hexavalent Chromium,"ZHITKOVICH, ANATOLY",BROWN UNIVERSITY,RI,"$254,306"
Lung Cancer,2012,NCI,5P50CA070907-15,0009,P-1: Molecular Signatures for Individualizing Lung Cancer Therapy,"MINNA, JOHN",UNIV OF TX SW MED CTR-DALLAS,TX,"$261,985"
Lung Cancer,2012,NCI,5P50CA070907-15,0010,P-2: Risk Prediction of platinum-based chemotherapy and Radiotherapy Outcome,"WU, XIFENG",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$355,330"
Lung Cancer,2012,NCI,5P50CA070907-15,0011,P-3: Targeting Tumor Microenvironment in NSCLC,"KURIE, JONATHAN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$250,764"
Lung Cancer,2012,NCI,5P50CA070907-15,0012,P-4: Therapeutic Targeting of Telomerase and Lung Cancer,"SHAY, JERRY",UNIV OF TX SW MED CTR-DALLAS,TX,"$181,888"
Lung Cancer,2012,NCI,5P50CA070907-15,0013,P-5: Translation of the 3p21.3 Gene FUS1 into Pathway-Targeted Molecular Therapy,"ROTH, JACK",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$282,866"
Lung Cancer,2012,NCI,5P50CA070907-15,0014,Developmental Research Program,"ROTH, JACK",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$71,378"
Lung Cancer,2012,NCI,5P50CA070907-15,9004,CB: Tissue Resources and Molecular Pathology,"WISTUBA, IGNACIO",UNIV OF TX SW MED CTR-DALLAS,TX,"$258,996"
Lung Cancer,2012,NCI,5P50CA070907-15,9005,CA: Administration Core,"MINNA, JOHN",UNIV OF TX SW MED CTR-DALLAS,TX,"$216,355"
Lung Cancer,2012,NCI,5P50CA070907-15,9006,CC: Biostatistics Core,"COOMBES, KEVIN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$238,548"
Lung Cancer,2012,NCI,5P50CA070907-15,9007,CD: Bioinformatics Core,"GARNER, HAROLD",UNIV OF TX SW MED CTR-DALLAS,TX,"$110,512"
Lung Cancer,2012,NCI,5P50CA070907-15,9008,Career Development Program,"ROTH, JACK",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$71,378"
Lung Cancer,2012,NCI,5P01CA138338-03,7507,Multiethnic Genome Scan of Metabolic Phenotypes,"LE MARCHAND, LOIC",UNIVERSITY OF HAWAII AT MANOA,HI,"$1,037,799"
Lung Cancer,2012,NCI,5P01CA138338-03,7509,Nicotine and NNK Glucuronidation Pathways on Smokers,"MURPHY, SHARON",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$102,634"
Lung Cancer,2012,NCI,5P01CA138338-03,7511,"Ethnic/Racial Differences in 1, 3-Bitadiene Metabolism and DNA Adduct Formation","TRETYAKOVA, NATALIA",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$132,807"
Lung Cancer,2012,NCI,5P01CA138338-03,7512,Ethnic/Racial Differences in DNA Repair,"PETERSON, LISA",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$132,805"
Lung Cancer,2012,NCI,5P01CA138338-03,7514,Metabolism of NNK among African Americans,"HATSUKAMI, DOROTHY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$132,763"
Lung Cancer,2012,NCI,5P01CA138338-03,7515,Administratice Core,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$30,665"
Lung Cancer,2012,NCI,5P01CA138338-03,7516,Tobacco Smoke Constituent Biomarker Core,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$246,983"
Lung Cancer,2012,NCI,5P01CA138338-03,7517,Biostatistics Core,"STRAM, DANIEL",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$232,714"
Lung Cancer,2012,NIEHS,5P42ES016465-04,6110,Project 1: Environmental PAH Mixtures as Skin and Transplacental Carcinogens,"BAIRD, WILLIAM",OREGON STATE UNIVERSITY,OR,"$310,948"
Lung Cancer,2012,NCI,5P50CA148110-03,6237,"SURGICAL DISPARITIES IN LUNG, PROSTATE, BREAST AND COLORECTAL CANCER IN AI/ANS","FLUM, DAVID",UNIVERSITY OF WASHINGTON,WA,"$300,358"
Lung Cancer,2012,NCI,5P01CA090890-08,6522,Transplacental Chemoprevention of Lung Tumors and Lymphomas,"WILLIAMS, DAVID",OREGON STATE UNIVERSITY,OR,"$216,317"
Lung Cancer,2012,NCI,5P50CA058187-18,0018,SEMA3F and ZEB1 in Lung Cancer: Therapy and Target Gene Discovery,"DRABKIN, HARRY",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$337,498"
Lung Cancer,2012,NCI,5P50CA058187-18,0019,Growth Factor Inhibitors for Lung Cancer Therapy and Prevention,"BUNN, PAUL",UNIVERSITY OF COLORADO DENVER,CO,"$267,151"
Lung Cancer,2012,NCI,5P50CA058187-18,0020,Prostacyclin and Peroxisome Proliferator- Activated Receptor Gamma in Lung Cancer,"NEMENOFF, RAPHAEL",UNIVERSITY OF COLORADO DENVER,CO,"$268,719"
Lung Cancer,2012,NCI,5P50CA058187-18,0021,The Biology of Pulmonary Premalignancy: Application to Risk Assessment and Chemop,"MILLER, YORK",UNIVERSITY OF COLORADO DENVER,CO,"$257,553"
Lung Cancer,2012,NCI,5P50CA058187-18,0022,Developmental Research Program,"BUNN, PAUL",UNIVERSITY OF COLORADO DENVER,CO,"$102,417"
Lung Cancer,2012,NCI,5P50CA058187-18,0023,Career Development Program,"MILLER, YORK",UNIVERSITY OF COLORADO DENVER,CO,"$102,416"
Lung Cancer,2012,NCI,5P50CA058187-18,9001,Tissue Bank and Biomarkers Core,"FRANKLIN, WILBUR",UNIVERSITY OF COLORADO DENVER,CO,"$293,675"
Lung Cancer,2012,NCI,5P50CA058187-18,9002,Clinical Trials Core,"KEITH, ROBERT",UNIVERSITY OF COLORADO DENVER,CO,"$260,584"
Lung Cancer,2012,NCI,5P50CA058187-18,9003,Biostatistics and Informatics Core,"BARON, ANNA",UNIVERSITY OF COLORADO DENVER,CO,"$249,607"
Lung Cancer,2012,NCI,5P50CA058187-18,9006,Administration Core,"BUNN, PAUL",UNIVERSITY OF COLORADO DENVER,CO,"$160,380"
Lung Cancer,2012,NCI,5P50CA148596-03,6423,IMPACT: INFLUENCING MEDIA & PUBLIC AGENDA ON CANCER & TOBACCO DISPARITIES,"VISWANATH, VISH",HARVARD SCHOOL OF PUBLIC HEALTH,,"$281,333"
Lung Cancer,2012,NCI,5P50CA148596-03,6424,TOBACCO TREATMENT OUTREACH TO REDUCE DISPARITIES FOR PRIMARY CARE POPULATIONS,"HAAS, JENNIFER",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$97,573"
Lung Cancer,2012,NCI,5P50CA148596-03,6425,RACIAL AND SOCIOECONOMIC DISPARITIES IN LUNG CANCER: A MULTIFACTORIAL ANALYSIS,"AYANIAN, JOHN",HARVARD UNIVERSITY,MA,"$62,580"
Lung Cancer,2012,NCI,5P50CA148596-03,6426,RACIAL DIFFERENCES IN LUNG ADENOCARCINOMA MUTATIONS,"MYERSON, MATTHEW",HARVARD UNIVERSITY,MA,"$91,782"
Lung Cancer,2012,NCI,5P50CA148596-03,6427,SOCIOECONOMIC ADJUSTMENT OF RACIAL DISPARITIES IN LUNG CANCER RELATIVE SURVIVAL,"CHEN, JARVIS",HARVARD UNIVERSITY,MA,"$18,320"
Lung Cancer,2012,NCI,5P50CA148596-03,6428,ADMINISTRATIVE,"WILLIAMS, DAVID",HARVARD UNIVERSITY,MA,"$119,254"
Lung Cancer,2012,NCI,5P50CA148596-03,6429,METHODS AND STATISTICS,"ZASLAVSKY, ALAN",HARVARD UNIVERSITY,MA,"$15,607"
Lung Cancer,2012,NCI,5P50CA148596-03,6431,DISSEMINATION AND PUBLIC HEALTH PRACTICE,"GELLER, ALAN",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$2,882"
Lung Cancer,2012,NCI,5P50CA148596-03,6432,TRAINING AND CAREER DEVELOPMENT,"SORENSEN, GLORIAN",DANA-FARBER CANCER INSTITUTE,MA,"$8,401"
Lung Cancer,2012,NIMHD,5P20MD003352-05,0001,The Effect of Isothiocyanate Consumption on NNAL Metabolism in Smokers,"HULL, ANNA",LINCOLN UNIVERSITY,PA,"$485,790"
Lung Cancer,2012,NCI,5P50CA090578-10,0011,Developmental Research Program,"JOHNSON, BRUCE",DANA-FARBER CANCER INSTITUTE,MA,"$145,734"
Lung Cancer,2012,NCI,5P50CA090578-10,0012,Career Development Program,"CHRISTIANI, DAVID",DANA-FARBER CANCER INSTITUTE,MA,"$145,734"
Lung Cancer,2012,NCI,5P50CA090578-10,9001,CA: Tissue and Pathology,"LODA, MASSIMO",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$684,809"
Lung Cancer,2012,NCI,5P50CA090578-10,9002,CC: Biostatistics,"YEAP, BEOW",MASSACHUSETTS GENERAL HOSPITAL,MA,"$377,063"
Lung Cancer,2012,NCI,5P50CA090578-10,9004,"CB: Administration, Evaluation, and Planning","JOHNSON, BRUCE",DANA-FARBER CANCER INSTITUTE,MA,"$619,944"
Lung Cancer,2012,NCI,5P50CA090578-10,9005,CD: Genomics and Bioinformatics,"MEYERSON, MATTHEW",DANA-FARBER CANCER INSTITUTE,MA,"$326,716"
Lung Cancer,2012,NCI,5U54CA156732-03,5439,Racial Disparities in Depression and Mental Healthcare Utilization in Lung Cancer,"CANNON, SHEILA",UNIVERSITY OF MASSACHUSETTS BOSTON,MA,"$2,901"
Lung Cancer,2012,NIEHS,5P42ES004940-23,5084,Project 3: Pulmonary Response to Toxicants In Susceptible Population,"LANTZ, ROBERT",UNIVERSITY OF ARIZONA,AZ,"$185,095"
Lung Cancer,2012,NCI,5U54CA112962-08,8629,Broad Institute Center for Cancer Systems Biology,"GOLUB, TODD","BROAD INSTITUTE, INC.",MA,"$2,155,481"
Lung Cancer,2012,NCI,5U54CA151838-03,5102,Mucus Penetrating Nanoparticles for Small Cell Lung Cancer,"HANES, JUSTIN",JOHNS HOPKINS UNIVERSITY,MD,"$146,476"
Lung Cancer,2012,NCI,5U54CA151459-03,8856,Magneto-Nano Diagnostic and Analytical Devices for Cancer,"WANG, SHAN",STANFORD UNIVERSITY,CA,"$262,335"
Lung Cancer,2012,NCI,5U54CA151459-03,8858,Integration of Nano-Molecular Imaging and Nanosensors,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$177,117"
Lung Cancer,2012,NCI,7U19CA148127-03,8822,Transdisciplinary Research in Cancer of the Lung- Discovery of Novel Variants,"AMOS, CHRISTOPHER",DARTMOUTH COLLEGE,,"$1,248,051"
Lung Cancer,2012,NCI,7U19CA148127-03,8823,Functional Studies of Candidate Lung Cancer Susceptibility Genes,"AMOS, CHRISTOPHER",DARTMOUTH COLLEGE,,"$531,503"
Lung Cancer,2012,NCI,7U19CA148127-03,8824,Epidemiologic Architedure of Lung Cancer and Smoking,"AMOS, CHRISTOPHER",DARTMOUTH COLLEGE,,"$624,146"
Lung Cancer,2012,NCI,7U19CA148127-03,8825,Administrative Core,"AMOS, CHRISTOPHER",DARTMOUTH COLLEGE,,"$232,371"
Lung Cancer,2012,NCI,5P50CA119997-05,0001,P1 - E2F's impact on Therapeutic Efficacy,"CRESS, DOUG",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$398,323"
Lung Cancer,2012,NCI,5P50CA119997-05,0002,P3 - Antitumor Mechanisms of SRC Inhibitors in Lung Cancer,"HAURA, ERIC",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$398,324"
Lung Cancer,2012,NCI,5P50CA119997-05,0003,P4 - Lung Cancer Chemoprevention with Enzastaurin,"BEPLER, GEROLD",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$398,324"
Lung Cancer,2012,NCI,5P50CA119997-05,0004,P5 - P-53-Based Vaccine for Small Cell Lung Cancer,"GABRILOVICH, DMITRY",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$398,324"
Lung Cancer,2012,NCI,5P50CA119997-05,0006,CDP - Career Development Program,"HAURA, ERIC",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$398,324"
Lung Cancer,2012,NCI,5P01CA021239-33,0007,Proton Dose Escalation and Proton vs. Photon Randomized Trials,"KOMAKI, RITSUKO",MASSACHUSETTS GENERAL HOSPITAL,MA,"$429,017"
Lung Cancer,2012,NCI,5U54CA151652-03,8811,Therapeutic Targeting of the Ras Pathway By Nanoparticle Delivery of siRNA,"HUANG, LEAF",UNIVERSITY OF N CAROLINA AT CHAPEL HILL,NC,"$155,168"
Lung Cancer,2012,NCI,5U54CA151652-03,8812,Translational Nanosystems for Improved Lung Cancer Treatment with Small Molecules,"MUMPER, RUSSELL",UNIVERSITY OF N CAROLINA AT CHAPEL HILL,NC,"$321,679"
Lung Cancer,2012,NCI,5U54CA151652-03,8816,Targeting Ligand Core,"LIU, RIHE",UNIVERSITY OF N CAROLINA AT CHAPEL HILL,NC,"$79,240"
Lung Cancer,2012,NCI,5U54CA151881-03,5126,Develop and High-Throughput Screening of Targeted Anticancer Nanomedicines,"PETRENKO, VALERY",AUBURN UNIVERSITY AT AUBURN,AL,"$313,331"
Lung Cancer,2012,NHLBI,5P01HL091842-05,9003,Imaging Core,"MCLENNAN, GEOFFREY",UNIVERSITY OF IOWA,IA,"$157,128"
Lung Cancer,2012,NCI,5P50CA095817-10,0005,ICCS in Lung Cancer: Evaluating Survival Benefits,"CLEARY, JAMES",UNIVERSITY OF WISCONSIN MADISON,WI,"$212,840"
Lung Cancer,2012,NCI,5P50CA127297-05,0003,P-4: Inhibitors of telomerase in treatment of Pancreatic Adenocarcinoma,"OUELLETTE, MICHEL",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$227,493"
Lung Cancer,2012,NCI,5P50CA114747-08,5347,Monitoring Response to Targeted Therapy in Non-Small Cell Lung Cancer Using 18F..,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$640,428"
Lung Cancer,2012,NCI,5P50CA114747-08,5349,Multi-Modality Imaging of Oncogene Addiction,"FELSHER, DEAN",STANFORD UNIVERSITY,CA,"$107,242"
Lung Cancer,2012,NCI,5P01CA136396-04,8565,Early Stage Lung Cancer,"KERNSTINE, KEMP",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$504,496"
Lung Cancer,2012,NCI,5P01CA136396-04,8566,Late Stage Lung Cancer,"FIGLIN, ROBERT",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$531,763"
Lung Cancer,2012,NCI,5P01CA136396-04,8567,Family Caregivers,"GRANT, MARCIA",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$540,656"
Lung Cancer,2012,NCI,5P01CA136396-04,8568,Administrative,"FERRELL, BETTY",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$172,144"
Lung Cancer,2012,NCI,5P01CA136396-04,8569,Biostatistics,"GRANT, MARCIA",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$193,661"
Lung Cancer,2012,NCI,5P01CA136396-04,8570,Geriatric,"HURRIA, ARTI",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$159,124"
Lung Cancer,2012,NCI,5U54CA153605-03,7802,Research Project,"PATTEN, CHRISTI",MAYO CLINIC,MN,"$567,188"
Lung Cancer,2012,NCI,1R01CA170386-01,,Novel Pathogen Associated Cancers (PQ12),"GALLOWAY, DENISE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$784,723"
Lung Cancer,2012,NCI,1R21CA164235-01A1,,Diindolylmethane:Inhibition of lung squamous cell carcinoma by targeting Akt.,"KASSIE, FEKADU",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$198,360"
Lung Cancer,2012,NCI,1K08CA163677-01A1,,Genomic Discovery and Targeted Therapeutics in Squamous Cell Lung Cancer,"HAMMERMAN, PETER",DANA-FARBER CANCER INSTITUTE,MA,"$177,120"
Lung Cancer,2012,NCI,1R21CA164515-01A1,,Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients,"HOFFMAN, AMY",MICHIGAN STATE UNIVERSITY,MI,"$213,251"
Lung Cancer,2012,NCI,1R21CA164568-01A1,,Validation of a risk model for stage I lung adenocarcinoma,"ADUSUMILLI, PRASAD",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$241,931"
Lung Cancer,2012,NCI,1R01CA165958-01A1,,"LACE-Bio-II: Identification, validation and implementation of prognostic and/or p","SEYMOUR, LESLEY",QUEEN'S UNIVERSITY AT KINGSTON,CANADA,"$443,119"
Lung Cancer,2012,NCI,1R01CA160455-01A1,,IKBKE/IKKE (epsilon) Kinase in Non-small Cell Lung Cancer,"CHENG, JIN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$349,638"
Lung Cancer,2012,NCI,2P01CA129243-06,6646,Mediators of Lung Adenocarcinoma Metastasis,"MASSAGUE, JOAN",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$259,338"
Lung Cancer,2012,NCI,2P01CA129243-06,6647,Targeting the ERK Pathway in KRAS-and BRAF-Driven Lung Cancers,"ROSEN, NEAL",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$254,404"
Lung Cancer,2012,NEI,1F32EY022558-01A1,,Understanding and enhancing visual search performance in complex scenes,"VO, MELISSA",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$53,942"
Lung Cancer,2012,NCI,1R43CA165450-01A1,,Therapeutic miRNAs in combination with conventional chemotherapy,"BADER, ANDREAS","MIRNA THERAPEUTICS, INC.",TX,"$299,999"
Lung Cancer,2012,NCI,2P01CA129243-06,6860,Mechanisms and Modulators of Sensitivity and Resistance to EGFR Inhibitors in Lu,"PAO, WILLIAM",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$399,448"
Lung Cancer,2012,NCI,2P01CA129243-06,6861,Lung Cancer Drivers and Dependencies as Therapeutic Targets,"LOWE, SCOTT",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$372,966"
Lung Cancer,2012,NCI,2P01CA129243-06,6862,Molecular Profiling and Pathology,"LADANYI, MARC",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$217,552"
Lung Cancer,2012,NCI,2P01CA129243-06,6863,Biostatistics and Bioinformatics,"SHEN, RONGLAI",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$143,832"
Lung Cancer,2012,NCI,2P01CA129243-06,6864,Administration,"KRIS, MARK",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$130,274"
Lung Cancer,2012,NCI,1R43CA171489-01,,Targeting stem cell populations in lung cancer by modulating the Wnt and p53 path,"ORTON, DARREN","STEMSYNERGY THERAPEUTICS, INC.",PA,"$259,451"
Lung Cancer,2012,NCI,2R44CA139841-02A1,,A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC,"PRABHAKARPANDIAN, BALABHASKAR",CFD RESEARCH CORPORATION,AL,"$633,309"
Lung Cancer,2012,NCI,1F32CA171857-01,,Dissecting the tumor suppressor function of LKB1 target kinases in lung cancer,"SVENSSON, ROBERT",SALK INSTITUTE FOR BIOLOGICAL STUDIES,CA,"$52,190"
Lung Cancer,2012,NCI,1F31CA165840-01A1,,Integrating cellular and molecular heterogeneity of TKI response in NSCLC cells,"FRICK, PETER",VANDERBILT UNIVERSITY MED CTR,TN,"$26,592"
Lung Cancer,2012,NCI,1F32CA165856-01A1,,Understanding the role of SKP2 in small cell lung cancer progression,"NICOLAY, BRANDON",MASSACHUSETTS GENERAL HOSPITAL,MA,"$49,214"
Lung Cancer,2012,NCI,1F32CA171878-01,,The study of novel miRNA in lung cancer initiation and metastasis,"EDMONDS, MICK",VANDERBILT UNIVERSITY MED CTR,TN,"$49,214"
Lung Cancer,2012,NCI,1R01CA166147-01A1,,Integrating Tobacco Treatment into Cancer Care,"PARK, ELYSE",MASSACHUSETTS GENERAL HOSPITAL,MA,"$738,480"
Lung Cancer,2012,NHLBI,1R13HL116010-01,,Translational Approaches to Reducing Health Disparities in Lung Disease,"GARCIA, JOE",UNIVERSITY OF ILLINOIS,IL,"$25,000"
Lung Cancer,2012,NCI,1R03CA171604-01,,Apple peel extract inhibits Cr(VI)-induced lung cancer,"ZHANG, ZHUO",UNIVERSITY OF KENTUCKY,KY,"$74,250"
Lung Cancer,2012,NCI,1R03CA171646-01,,Development of a novel agent for lung cancer prevention,"SHARMA, ARUN",PENNSYLVANIA STATE UNIVERSITY,PA,"$75,588"
Lung Cancer,2012,RMAP,1R03DA035193-01A1,,Screening of inhibitors for human 5-prime-tyrosyl DNA phosphodiesterase (hTDP2),"ADHIKARI, SANJAY",GEORGETOWN UNIVERSITY,DC,"$38,750"
Lung Cancer,2012,NCI,5R01CA122244-05,,Randomized trial of PEITC as a modifier of NNK metabolism in smokers,"YUAN, JIAN-MIN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$542,156"
Lung Cancer,2012,NCI,4R00CA149144-02,,The Role of Sulfiredoxin in Tumorigenesis and Cancer Progression.,"WEI, QIOU",UNIVERSITY OF KENTUCKY,KY,"$249,000"
Lung Cancer,2012,NCI,2P01CA120964-06A1,7579,LKB1/AMPK signaling and Peutz-Jeghers syndrome,"CANTLEY, LEWIS",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$213,704"
Lung Cancer,2012,NCI,2P01CA120964-06A1,7580,Integrated analyses of cancers harboring STK11 vs. TSC1/2 vs. PTEN Loss,"KWIATKOWSKI, DAVID",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$540,360"
Lung Cancer,2012,RMAP,1R01ES022191-01,,Integrated Chemoselective and Informatic Platform for Large-Scale Metabolomics,"FAN, TERESA",UNIVERSITY OF LOUISVILLE,KY,"$446,581"
Lung Cancer,2012,NCI,1R01CA172468-01,,Dual Targeting of the p53 pathway for development of anti-cancer therapy,"LU, HUA",TULANE UNIVERSITY OF LOUISIANA,LA,"$294,134"
Lung Cancer,2012,NCI,261201100054C-2-0-1,,R&D-OTHER SCIENCES-B RES,"GOYAL, ANIL K.","QUALIBER, INC.",NC,"$179,834"
Lung Cancer,2012,NCI,1R01CA166376-01A1,,A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer,"NGUYEN, DON",YALE UNIVERSITY,CT,"$385,406"
Lung Cancer,2012,NCI,5R01CA127219-06,,Inflammation Genes and Lung Cancer Risk,"SPITZ, MARGARET",BAYLOR COLLEGE OF MEDICINE,TX,"$510,315"
Lung Cancer,2012,NCI,2P01CA120964-06A1,7268,LKB1/AMPK signaling and Peutz-Jeghers syndrome,"SHAW, REUBEN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$279,121"
Lung Cancer,2012,NCI,1R43CA165848-01A1,,Targeting the ERCC1/XPF nuclease for cancer therapy,"FELTGEN, ROBERT","NERX BIOSCIENCES, INC.",IN,"$299,922"
Lung Cancer,2012,NCI,2R44CA162613-02,,Targeted Treatment of Recurrent Small Cell Lung Cancer with Anti-AbnV2 Antibodies,"PANG, ROY","WOOMERA THERAPEUTICS, INC.",NH,"$491,150"
Lung Cancer,2012,NIEHS,3R01ES009132-10S1,,Molecular mechanism of cytochrome P4501A1 expression.,"MOORTHY, BHAGAVATULA",BAYLOR COLLEGE OF MEDICINE,TX,"$53,881"
Lung Cancer,2012,NCI,4R00CA149169-03,,"Defining lineage-specific determinants of K-Ras ""addiction"" in human cancers","SINGH, ANURAG",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$249,000"
Lung Cancer,2012,NIGMS,1P20GM103639-01,7851,MOLECULAR DETERMINANTS OF GEMCITABINE (Franklin Hays),"HAYS, FRANKLIN",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$221,929"
Lung Cancer,2012,NCI,3RC2CA148225-02S1,,A Concerted Attack on Patient Specific Oncogenic Vulnerabilities in Lung Cancer,"ROTH, MICHAEL",UNIV OF TX SW MED CTR-DALLAS,TX,"$595,625"
Lung Cancer,2012,NCI,1U54CA163071-01A1,7987,Molecular Biology of Lung Cancer among Puerto Ricans,"SANTIAGO, PEDRO",PONCE SCHOOL OF MEDICINE,PR,"$190,379"
Lung Cancer,2012,NCI,1U54CA163068-01A1,8053,Molecular Biology of Lung Cancer among Puerto Ricans,"CRESS, DOUG",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$111,240"
Lung Cancer,2012,NCI,2P30CA046934-24,8115,"LUNG, HEAD AND NECK CANCERS","MILLER, YORK",UNIVERSITY OF COLORADO DENVER,CO,"$36,987"
Lung Cancer,2012,NCI,N02CN63300-11-0-2,,Computer Support for Lung Cancer Screening in the PLCO Cancer Screening Trial,"LAKE, WILLIAM","INFORMATION MANAGEMENT SERVICES, INC.",MD,"$1,068,862"
Lung Cancer,2012,NCI,3R01CA157850-02S1,,Rationally designed targeted therapeutic approaches for NSCLC,"DEGREGORI, JAMES",UNIVERSITY OF COLORADO DENVER,CO,"$32,009"
Lung Cancer,2012,NCI,261201100066C-2-0-1,,RAPID BREATH DETECTION OF LUNG CANCER,"RHODES, PAUL",ISENSE MEDICAL CORPORATION,FL,"$971,442"
Lung Cancer,2012,NCI,3P50CA148110-03S1,6237,"SURGICAL DISPARITIES IN LUNG, PROSTATE, BREAST AND COLORECTAL CANCER IN AI/ANS","FLUM, DAVID",UNIVERSITY OF WASHINGTON,WA,"$2,617"
Lung Cancer,2012,OD,3R01CA133470-04S1,,Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy,"CHRISTOFIDOU-SOLOMIDOU, MELPO",UNIVERSITY OF PENNSYLVANIA,PA,"$250,000"
Lung Cancer,2012,NCI,7R01CA124495-05,,The Role of RAC1 in Cancer,"KISSIL, JOSEPH",SCRIPPS FLORIDA,FL,"$148,500"
Lung Cancer,2012,NCI,3R01CA140409-03S1,,Development of Small Molecule Radiation Sensitizers,"FREEMAN, MICHAEL",VANDERBILT UNIVERSITY MED CTR,TN,"$15,600"
Lung Cancer,2012,NCI,3P01CA116676-05S2,0001,Modulation of the mTOR Pathway for Lung Cancer Treatment,"KHURI, FADLO",EMORY UNIVERSITY,GA,"$249,999"
Lung Cancer,2012,NCI,4R00CA151968-03,,Functional Characterization of Lung Adenocarcinoma Progression and Metastasis,"WINSLOW, MONTE",STANFORD UNIVERSITY,CA,"$246,227"
Lung Cancer,2012,NCI,3P50CA119997-05S1,,SPORE in Lung Cancer,"HAURA, ERIC",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$94,360"
Lung Cancer,2012,NCI,3P30CA077598-14S1,5746,Carcinogenesis & Chemoprevention,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$2,679"
Lung Cancer,2012,NCI,3U10CA021661-36S1,,Radiation Therapy Oncology Group,"CURRAN, WALTER",AMERICAN COLLEGE OF RADIOLOGY,VA,"$172,284"
Lung Cancer,2012,NCI,3P30CA077598-14S2,5746,Carcinogenesis & Chemoprevention,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$1,776"
Lung Cancer,2012,NCI,3R01CA084354-10S1,,Genetic Determinants of Lung Cancer Survival,"YANG, PING",MAYO CLINIC,MN,"$227,213"
Lung Cancer,2012,NCI,3U54CA112962-08S1,8629,Broad Institute Center for Cancer Systems Biology,"GOLUB, TODD","BROAD INSTITUTE, INC.",MA,"$44,814"
Lung Cancer,2012,NCI,3R44CA135967-02A1S1,,Prevention of Tumor Recurrence Following Surgical Resection (Phase II),"WOLINSKY, JESSE","FIFTH BASE, LLC",MA,"$92,710"
Lung Cancer,2012,NIEHS,AES12007001-1-0-2,,Investigations into Health Effects Caused by Exposure to indoor air reaction prod,NO PI IDENTIFIED,NIH,,"$45,000"
Lung Cancer,2012,NCI,3R01CA160522-01A1S1,,Therapeutic potential of mTOR kinase inhibitors in lung cancer,"SUN, SHI-YONG",EMORY UNIVERSITY,GA,"$164,541"
Lung Cancer,2012,NCI,3U01CA152956-03S2,,Comparative Modeling of Lung Cancer Control Policies,"MCMAHON, PAMELA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$109,989"
Lung Cancer,2012,NCI,1U54CA163068-01A1,8819,Molecular Biology of Lung Cancer among Puerto Ricans,"CRESS, DOUG",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$111,238"
Lung Cancer,2012,NCI,1ZIABC005480-27,,Molecular Epidemiology of Human Lung Cancer,"HARRIS, CURTIS",NIH,,"$803,200"
Lung Cancer,2012,NCI,1ZIABC010033-17,,Inflammation and  Cancer,"HARRIS, CURTIS",NIH,,"$803,200"
Lung Cancer,2012,NCI,1ZIABC010298-15,,Growth Regulation Section,"PASTAN, IRA",NIH,,"$194,423"
Lung Cancer,2012,NCI,1ZIABC010328-13,,Role of CEBP transcription factors in regulating cell growth and tumorigenesis,"JOHNSON, PETER",NIH,,"$1,327,149"
Lung Cancer,2012,NCI,1ZIABC010448-11,,Genetic Alterations in Lung Cancer,"WIEST, JONATHAN",NIH,,"$250,510"
Lung Cancer,2012,NCI,1ZIABC010449-11,,Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung,"KIMURA, SHIOKO",NIH,,"$565,375"
Lung Cancer,2012,NCI,1ZIABC010499-10,,Maryland Prostate Cancer Case-Control Study,"AMBS, STEFAN",NIH,,"$668,844"
Lung Cancer,2012,NCI,1ZIABC010646-09,,Chromatin Remodeling Proteins,"HAGER, GORDON",NIH,,"$332,833"
Lung Cancer,2012,NCI,1ZIABC010661-08,,Vaccine and Drug Combination Therapy for Human Cancers,"HODGE, JAMES",NIH,,"$386,587"
Lung Cancer,2012,NCI,1ZIABC010748-07,,Clinical Investigation of Signal Transduction Inhibitors,"DENNIS, PHILLIP",NIH,,"$249,890"
Lung Cancer,2012,NCI,1ZIABC010816-06,,Immunotherapy for Malignant Mesothelioma,"HASSAN, RAFFIT",NIH,,"$914,751"
Lung Cancer,2012,NCI,1ZIABC010853-06,,Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide,"KLINMAN, DENNIS",NIH,,"$374,896"
Lung Cancer,2012,NCI,1ZIABC010874-05,,Biomarkers of Human Lung Cancer,"HARRIS, CURTIS",NIH,,"$803,200"
Lung Cancer,2012,NCI,1ZIABC010891-05,,Antibody Therapy of Cancer,"HO, MITCHELL",NIH,,"$735,484"
Lung Cancer,2012,NCI,1ZIABC010944-05,,Strategies for Cancer Vaccine Development:  Preclinical Studies,"SCHLOM, JEFFREY",NIH,,"$612,693"
Lung Cancer,2012,NCI,1ZIABC010972-05,,Identification of human tumor-associated antigens,"TSANG, KWONG YOK",NIH,,"$887,872"
Lung Cancer,2012,NCI,1ZIABC011046-05,,Mechanisms of apoptosis regulation which impede cancer cell death in lung cancer,"KWONG, KING",NIH,,"$364,378"
Lung Cancer,2012,NCI,1ZIABC011049-05,,Development and evaluation of apoptosis targeted therapies in lung cancer,"KWONG, KING",NIH,,"$364,378"
Lung Cancer,2012,NCI,1ZIABC011108-05,,MAP Kinase signal transduction disruption in cancer,"WIEST, JONATHAN",NIH,,"$250,510"
Lung Cancer,2012,NCI,1ZIABC011115-05,,Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells,"SCHRUMP, DAVID",NIH,,"$486,527"
Lung Cancer,2012,NCI,1ZIABC011122-05,,Epigenetic Alterations Induced by Tobacco Smoke,"SCHRUMP, DAVID",NIH,,"$486,527"
Lung Cancer,2012,NCI,1ZIABC011160-04,,Mechanisms in development and regulation of metastasis in lung cancer,"KWONG, KING",NIH,,"$80,972"
Lung Cancer,2012,NCI,1ZIABC011167-04,,A novel preclinical model of spontaneous metastasis,"MERLINO, GLENN",NIH,,"$412,046"
Lung Cancer,2012,NCI,1ZIABC011184-04,,Mechanism of Radiation Affects on microRNA,"SIMONE, NICOLE",NIH,,"$4,569"
Lung Cancer,2012,NCI,1ZIABC011188-04,,Diazeniumdiolates as Broad-Spectrum Anticancer Agents,"KEEFER, LARRY",NIH,,"$909,984"
Lung Cancer,2012,NCI,1ZIABC011204-04,,Preclinical development of Ala+TIMP-2 as an cancer therapeutic,"STETLER-STEVENSON, WILLIAM",NIH,,"$1,128,123"
Lung Cancer,2012,NCI,1ZIABC011212-04,,Functions of IKK alpha in Skin Homeostasis and Skin Tumorigenesis,"HU, YINLING",NIH,,"$482,048"
Lung Cancer,2012,NCI,1ZIABC011217-04,,Preclinical Characterization of Drugs in Mouse Model of Lung Cancer,"VAN DYKE, TERRY",NIH,,"$1,051,828"
Lung Cancer,2012,NCI,1ZIABC011269-03,,Thoracic Cancer Research Laboratory,"GIACCONE, GIUSEPPE",NIH,,"$1,696,598"
Lung Cancer,2012,NCI,1ZIABC011314-03,,Development of antibacterial agents and materials,"SCHNEIDER, JOEL",NIH,,"$551,535"
Lung Cancer,2012,NCI,1ZIABC011391-02,,Role of IKK alpha in lung squamous cell carcinoma development,"HU, YINLING",NIH,,"$482,048"
Lung Cancer,2012,NCI,1ZIABC011399-02,,Regulation of microRNA expression by Mutant p53,"LAL, ASHISH",NIH,,"$237,448"
Lung Cancer,2012,NCI,1ZIABC011400-02,,Function of Mutant p53-regulated microRNAs in cancer cells,"LAL, ASHISH",NIH,,"$316,598"
Lung Cancer,2012,NCI,1ZIABC011401-02,,Mechanisms regulating the context-dependant function of microRNAs,"LAL, ASHISH",NIH,,"$118,725"
Lung Cancer,2012,NCI,1ZIABC011410-02,,Protein phosphorylation downstream of mutant EGFR kinases,"GUHA, UDAYAN",NIH,,"$493,134"
Lung Cancer,2012,NCI,1ZIABC011412-02,,Role of ERRFI1 in mutant EGFR-driven lung tumorigenesis,"GUHA, UDAYAN",NIH,,"$369,851"
Lung Cancer,2012,NCI,1ZIABC011414-02,,Identification of potentially active tyrosine kinases in lung cancer,"GUHA, UDAYAN",NIH,,"$246,567"
Lung Cancer,2012,NCI,1ZIABC011418-02,,Modulating Cancer Stem Cell Signaling in Thoracic Malignancies,"SCHRUMP, DAVID",NIH,,"$486,527"
Lung Cancer,2012,NCI,1ZIABC011422-01,,Role of IKKalpha in lymphoid organ development,"HU, YINLING",NIH,,"$107,122"
Lung Cancer,2012,NIEHS,1ZIAES046008-22,,Genetic Susceptibility To Carcinogens and Toxicants,"BELL, DOUGLAS",NIH,,"$395,184"
Lung Cancer,2012,NIEHS,1ZIAES049028-16,,Environmental Exposures And Risk For Cancer and Chronic Diseases In Adults,"SANDLER, DALE",NIH,,"$23,366"
Lung Cancer,2012,NIEHS,1ZIAES102925-03,,Inorganic Toxicology,"WAALKES, MICHAEL",NIH,,"$3,474,262"
Lung Cancer,2012,NCI,1ZIASC000167-21,,Molecular Pathology of Pulmonary Carcinogenesis,"LINNOILA, ILONA",NIH,,"$1,148,959"
Lung Cancer,2012,NCI,1ZIASC009179-24,,The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis,"STETLER-STEVENSON, WILLIAM",NIH,,"$752,082"
Lung Cancer,2012,NCI,1ZIASC010093-16,,Targeting the Epigenome for Lung Cancer Therapy,"SCHRUMP, DAVID",NIH,,"$486,527"
Lung Cancer,2012,NCI,1ZIASC010292-14,,Signal Transduction Pathways that Promote Survival of Lung Cancer Cells,"DENNIS, PHILLIP",NIH,,"$499,781"
Lung Cancer,2012,NCI,1ZICBC010937-05,,Novel Targets for Vaccine Therapy,"PALENA, CLAUDIA",NIH,,"$848,816"
Lung Cancer,2012,NCI,1ZICBC010981-05,,"Design, Develop, Validate, and Implement Biomarkers for Clinical Investigations","CAO, LIANG",NIH,,"$356,520"
Lung Cancer,2012,NCI,1ZICBC011040-05,,Molecular Profiling of Clinical Specimens,"EDELMAN, DANIEL",NIH,,"$1,874,339"
Lung Cancer,2012,NCI,5P01CA087971-10,5098,Enhancing Direct Tumor Cell Cytotoxicity By Manipulating Growth Factor Signaling,"HAHN, STEPHEN",UNIVERSITY OF PENNSYLVANIA,PA,"$201,439"
Lung Cancer,2012,NCI,5P01CA087971-10,5101,PDT for NSCLC with pleural carcinomatosis,"FRIEDBERG, JOSEPH",UNIVERSITY OF PENNSYLVANIA,PA,"$155,884"
Lung Cancer,2012,NCI,5P01CA087971-10,5104,Biostatistics and Data Coordinating Core (BDCC),"PUTT, MARY",UNIVERSITY OF PENNSYLVANIA,PA,"$173,617"
Lung Cancer,2012,NCI,5U54CA143906-04,5193,Dyn-omics,"KUHN, PETER",SCRIPPS RESEARCH INSTITUTE,CA,"$120,378"
Lung Cancer,2012,NCI,5U54CA143798-04,5199,Education & Training,"MICHOR, FRANZISKA",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$50,977"
Lung Cancer,2012,NCI,5U54CA143798-04,5200,Developing Mathmatical Framework to Uncover the Sequence of Genetic Events During,"MICHOR, FRANZISKA",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$657,010"
Lung Cancer,2012,NCI,5U54CA143798-04,5201,The Cell-Of-Origin of Human Cancers,"HOLLAND, ERIC",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$426,783"
Lung Cancer,2012,NCI,5U54CA143798-04,5202,Novel Tools to Predict and Prevent the Emergence of Resistance Against Targeted,"MICHOR, FRANZISKA",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$466,295"
Lung Cancer,2012,NCI,5U54CA143798-04,5203,Single Cell Measurement Core Facility,"ALTAN-BONNET, GREGOIRE",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$336,386"
Lung Cancer,2012,NCI,5U54CA143798-04,5204,Outreach and Dissemination,"MICHOR, FRANZISKA",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$36,733"
Lung Cancer,2012,NCI,5P50CA090440-12,5225,Selective Targeting of Estrogen Pathways in Lung Cancer Using Biomarkers,"SIEGFRIED, JILL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$263,971"
Lung Cancer,2012,NCI,5P50CA090440-12,5226,Vitamin D3 Modulation of Inflammation and Lung Cancer Risk,"DIERGAARDE, BRENDA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$286,475"
Lung Cancer,2012,NCI,5P50CA090440-12,5227,Lung Cancer Risk Prediction in the Pittsburgh Lung Screening Study (PLuSS) Cohort,"BIGBEE, WILLIAM",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$318,815"
Lung Cancer,2012,NCI,5P50CA090440-12,5228,Targeting Neutrophil Elastase in Lung Cancer,"SHAPIRO, STEVEN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$272,617"
Lung Cancer,2012,NCI,5P50CA090440-12,5229,Administrative Core,"SIEGFRIED, JILL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$180,603"
Lung Cancer,2012,NCI,5P50CA090440-12,5230,Core B: Clinical Core,"WEISSFELD, JOEL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$579,763"
Lung Cancer,2012,NCI,5P50CA090440-12,5231,Tissue and Blood Bank Core,"DACIC, SANJA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$155,346"
Lung Cancer,2012,NCI,5P50CA090440-12,5232,BIOSTATISTICS/BIOINFORMATICS CORE,"LAND, STEPHANIE",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$242,410"
Lung Cancer,2012,NCI,5U54CA163109-02,5393,Investigating the Tumor Microenvironment in Tumor Progression and Metastasisin Lu,"JACKS, TYLER",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$235,883"
Lung Cancer,2012,NCI,5P30CA016520-36,5523,Tobacco and Environmental Carcinogenesis Program,"LERMAN, CARYN",UNIVERSITY OF PENNSYLVANIA,PA,"$149,957"
Lung Cancer,2012,NCI,261201200086C-0-0-1,,OTHER FUNCTIONS - R&D BIOMEDICAL (BASIC RESEARCH),"HOUT, DR. DAVID","INSIGHT GENETICS, INC.",TN,"$199,576"
Lung Cancer,2012,NCI,261201200015I-0-26100002-1,,Anti-inflammatory effects of Pioglitazone & Metformin for Lung Cancer Prevention,NO PI IDENTIFIED,INSTITUTE FOR CANCER RESEARCH,PA,"$547,860"
Lung Cancer,2012,NCI,261201200047C-0-0-1,,OTHER FUNCTIONS DEVELOPMENT OF A COMPANION DIAGNOSTIC FOR ALK MUTATIONS.,"HOUT, DAVID","INSIGHT GENETICS, INC.",TN,"$1,495,220"
Lung Cancer,2012,NCI,261201200048C-0-0-1,,OTHER FUNCTIONS PHASE 0 CARBOPLATIN MICRODOSING DIAGNOSTIC TRIAL.,"HENDERSON, PAUL","ACCELERATED MEDICAL DIAGNOSTICS, LLC",CA,"$1,499,894"
Lung Cancer,2012,NCI,261201200043C-0-0-1,,"OTHER FUNCTIONS: TOPIC 287, PHASE II ""NANOTECHNOLOGY SENSING PLATFORMS""","CHAKRAVARTY, SWAPNAJIT","OMEGA OPTICS, INC.",TX,"$1,000,000"
Lung Cancer,2012,NCI,261201200052C-0-0-1,,"OTHER FUNCTIONS ""DEVELOPMENT OF A UNI-DIRECTIONAL BRACHYTHERAPY DEVICE FOR THE T","PEREZ, KRISTY","CIVATECH ONCOLOGY, INC.",NC,"$998,964"
Lung Cancer,2012,NHLBI,1ZIAHL000202-41,,Biochemical Mechanisms of Enzyme Action and Cellular Regulation,"CHOCK, P.",NIH,,"$708,889"
Lung Cancer,2012,NCI,261201200013I-0-26100002-1,,"Efficacy - In Vivo Evaluation of a Chemopreventive Agent, Ciclesonide, in Mouse",NO PI IDENTIFIED,UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$365,534"
Lung Cancer,2012,NCI,261201200468P-0-0-1,,Simulation Modeling to Develop Population-Based  Lung Cancer Screening Guidelines,"ARNOLD, HEATHER",DARTMOUTH COLLEGE,NH,"$24,904"
Lung Cancer,2012,NCI,1ZIACP000176-08,,Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners,"TAYLOR, PHILIP",NIH,,"$155,737"
Lung Cancer,2012,NCI,1ZIACP005804-18,,Pharmacogenetic Studies,"CAPORASO, NEIL",NIH,,"$1,046,660"
Lung Cancer,2012,NCI,1ZIACP010120-17,,Studies of Occupational Cancer,"LAN, QING",NIH,,"$1,860,441"
Lung Cancer,2012,NCI,1ZIACP010125-17,,Cancer Risk and Environmental Exposures,"WARD, MARY",NIH,,"$1,796,739"
Lung Cancer,2012,NCI,1ZIACP010134-17,,Studies of Atomic Bomb Survivors,"MABUCHI, KIYOHIKO",NIH,,"$860,011"
Lung Cancer,2012,NCI,1ZIACP010135-17,,Studies of Non-Ionizing Radiation-Related Cancer,"INSKIP, PETER",NIH,,"$258,356"
Lung Cancer,2012,NCI,1ZIACP010169-11,,"Nutrition, Metabolism, and Cancer","ZIEGLER, REGINA",NIH,,"$940,099"
Lung Cancer,2012,NCI,1ZIACP010184-10,,Consultation and Collaboration,"GRAUBARD, BARRY",NIH,,"$1,838,536"
Lung Cancer,2012,NCI,1ZIACP010200-05,,GEI - Genome-Wide Association Studies,"CAPORASO, NEIL",NIH,,"$167,654"
Lung Cancer,2012,NHGRI,1ZIAHG000153-14,,Development of statistical genetics methodology,"BAILEY-WILSON, JOAN",NIH,,"$444,812"
Lung Cancer,2012,NHGRI,1ZIAHG200331-08,,Genetic Epidemiology of Cancer,"BAILEY-WILSON, JOAN",NIH,,"$811,554"
Lung Cancer,2012,NCI,261201200078C-0-0-1,,Development of BIO300 as a Radiomodulator for Use During Radiation Therapy,NO PI IDENTIFIED,HUMANETICS CORPORATION,MN,"$197,224"
Lung Cancer,2012,NHGRI,1ZIAHG200375-02,,Cancer Biology and Genetics,"VARMUS, HAROLD",NIH,,"$1,321,500"
Lung Cancer,2012,NCI,5U54CA143798-04,6147,Center Organization and Infrastructure Unit,"MICHOR, FRANZISKA",DANA-FARBER CANCER INSTITUTE,MA,"$145,617"
Lung Cancer,2012,NCI,5U54CA143798-04,6148,Pilot Projects/Trans-Network,"MICHOR, FRANZISKA",DANA-FARBER CANCER INSTITUTE,MA,"$130,845"
Lung Cancer,2012,NCI,261200800001E-51-0-105,,OCG Web Transition and Development,NO PI IDENTIFIED,"SAIC-FREDERICK, INC.",MD,"$544,931"
